<SEC-DOCUMENT>0001493152-21-020581.txt : 20210818
<SEC-HEADER>0001493152-21-020581.hdr.sgml : 20210818
<ACCEPTANCE-DATETIME>20210818172141
ACCESSION NUMBER:		0001493152-21-020581
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20210818
FILED AS OF DATE:		20210818
DATE AS OF CHANGE:		20210818

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Microbot Medical Inc.
		CENTRAL INDEX KEY:			0000883975
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				943078125
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-19871
		FILM NUMBER:		211187539

	BUSINESS ADDRESS:	
		STREET 1:		25 RECREATION PARK DR SUITE 108
		CITY:			HINGHAM
		STATE:			MA
		ZIP:			02043
		BUSINESS PHONE:		908-938-5561

	MAIL ADDRESS:	
		STREET 1:		25 RECREATION PARK DR SUITE 108
		CITY:			HINGHAM
		STATE:			MA
		ZIP:			02043

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	STEMCELLS INC
		DATE OF NAME CHANGE:	20000524

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CYTOTHERAPEUTICS INC/DE
		DATE OF NAME CHANGE:	19930328
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>formdef14a.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>Washington,
D.C. 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>SCHEDULE
14A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Rule
14a-101)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INFORMATION
REQUIRED IN PROXY STATEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SCHEDULE
14A INFORMATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proxy
Statement Pursuant To Section 14(a) of the Securities Exchange Act of 1934</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
by the Registrant [X]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
by a Party other than the Registrant [&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Check
the appropriate box:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preliminary
    Proxy Statement</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Confidential,
    for Use of the Commissions Only (as permitted by Rule 14a-6(e)(2))</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[X]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitive
    Proxy Statement</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitive
    Additional Materials</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    Material Pursuant to Section 240.14a-12</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>MICROBOT
    MEDICAL INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name
    of Registrant as Specified in its Charter)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>N/A</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name
    of Person(s) Filing Proxy Statement, if other than the Registrant)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Payment
of filing fee (Check the appropriate box):</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[X]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    fee required.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fee
    computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of each class of securities to which transaction applies:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aggregate
    number of securities to which transaction applies:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Per
    unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the
    filing fee is calculated and state how it was determined):</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposed
    maximum aggregate value of transaction:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    fee paid:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fee
    paid previously with preliminary materials.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
    box if any part of the fee is offset as provided by Exchange Act Rule 0-11 (a)(2) and identify the filing for which the offsetting
    fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its
    filing.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form,
    Schedule or Registration Statement No.:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filing
    Party:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
    Filed:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; border-bottom: Black 4pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MICROBOT
MEDICAL INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>25
Recreation Park Drive, Unit 108</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Hingham,
MA 02043</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF ANNUAL MEETING OF SHAREHOLDERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TO
BE HELD ON SEPTEMBER 29, 2021</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dear
Shareholders:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTICE
IS HEREBY GIVEN, that the 2021 Annual Meeting of Shareholders (the &ldquo;Annual Meeting&rdquo;) of Microbot Medical Inc. (the &ldquo;Company&rdquo;)
will be held at 11:00 A.M., Eastern Time on September 29, 2021 at the offices of the Company, located at 25 Recreation Park Drive, Unit
108, Hingham, MA 02043. At the Annual Meeting, you will be asked to vote on:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    election of two Class III directors to the Board of Directors of the Company to serve until the 2024 Annual Meeting of Shareholders;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    ratification of Brightman Almagor Zohar &amp; Co., a Member of Deloitte Touche Tohmatsu Limited, or its U.S. affiliate, as the Company&rsquo;s
    independent registered public accounting firm for the year ending December 31, 2021;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    transact such other and further business as may properly come before the meeting or any adjournment thereof.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board of Directors has fixed the close of business on July 21, 2021 as the record date for determining shareholders who are entitled
to receive notice of, and to vote at, the Annual Meeting or any adjournment or postponement thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Your
vote is important to us. Whether or not you intend to be present at the meeting, please sign and date the enclosed proxy card and return
it in the enclosed envelope. Returning a proxy will not deprive you of your right to attend the Annual Meeting and vote your shares in
person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing items of business are more fully described in the accompanying proxy statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
Order of the Board of Directors,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Harel
Gadot</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman,
President and Chief Executive Officer</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
August 18, 2021</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hingham,
Massachusetts</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MICROBOT
MEDICAL INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>25
Recreation Park Drive, Unit 108</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Hingham,
MA 02043</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROXY
STATEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2021
ANNUAL MEETING OF SHAREHOLDERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>August
18, 2021</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
proxy statement and the accompanying proxy card is furnished in connection with the solicitation by the Board of Directors (the &ldquo;Board&rdquo;)
of Microbot Medical Inc., a Delaware corporation (the &ldquo;Company&rdquo;), of proxies for use at the 2021 Annual Meeting of Shareholders
(the &ldquo;Annual Meeting&rdquo;) to be held at the offices of the Company, located at 25 Recreation Park Drive, Unit 108, Hingham,
MA 02043, at 11:00 A.M., Eastern Time, on September 29, 2021, or at any adjournment or postponement thereof, for the purposes set forth
in this proxy statement and the accompanying Notice of Annual Meeting of Shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is making available to you over the Internet or delivering paper copies of this proxy statement, a proxy card and
the Company&rsquo;s 2021 Annual Report on Form 10-K for the fiscal year ended December 31, 2020 (the &ldquo;Annual Report&rdquo;), in
connection with the Annual Meeting. The Company is using the rules of the Securities and Exchange Commission (&ldquo;SEC&rdquo;) that
allow companies to furnish their proxy materials over the Internet. As a result, the Company is mailing to many of its stockholders a
notice about the Internet availability of the proxy materials instead of a paper copy of the proxy materials. All stockholders receiving
the notice will have the ability to access the proxy materials over the Internet, as well as to request a paper copy by mail or via email,
free of charge, by following the instructions in the notice. The notice about the Internet availability of the proxy materials
is first being mailed on or about August 19, 2021 to all shareholders of the Company entitled to vote at the Annual Meeting (the
&ldquo;Shareholders&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will bear the cost of solicitation of proxies. Directors, officers and employees of the Company may solicit proxies by telephone,
email, facsimile, in person or otherwise for no additional compensation. The Company will pay the entire costs of such solicitation as
well as the costs of printing and filing this proxy statement and proxy card. The Company will reimburse banks, brokerage firms, proxy
solicitors, and other custodians, nominees and fiduciaries for reasonable expenses incurred by them in sending proxy materials to the
beneficial owners of shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board of Directors has fixed the close of business on July 21, 2021, as the record date for determining stockholders entitled to notice
of, and to vote at, the Annual Meeting or at any postponement or adjournment thereof. There were 7,108,133 shares of our common stock,
$.01 par value, outstanding on July 21, 2021, each of which is entitled to one vote for each share on the matters to be voted upon.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholders
are being asked to vote on two proposals at the Company&rsquo;s 2021 Annual Meeting. The proposals to be voted on and related recommendations
from the Board of Directors are as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposal
    Number 1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    election of two Class III directors to the Board of the Company to serve until the 2024 Annual Meeting of Shareholders. The Board
    recommends that you vote &ldquo;FOR&rdquo; each of the nominees.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposal
    Number 2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    ratification of Brightman Almagor Zohar &amp; Co., a Member of Deloitte Touche Tohmatsu Limited, or its U.S. affiliate, as the Company&rsquo;s
    independent registered public accounting firm for the year ending December 31, 2021. The Board recommends that you vote &ldquo;FOR&rdquo;
    this proposal.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the election of directors, which is Proposal Number 1, you may vote &ldquo;FOR&rdquo; both of the nominees or your vote may be &ldquo;WITHHELD&rdquo;
with respect to one or both of the nominees. For Proposal Number 2, you may vote &ldquo;FOR,&rdquo; vote &ldquo;AGAINST&rdquo; or &ldquo;ABSTAIN.&rdquo;
If you &ldquo;ABSTAIN&rdquo; as to Proposal Number 2, the abstention will have no effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
of our common stock represented by proxies in the form enclosed that are properly executed and returned to us and not revoked will be
voted as specified in the proxy by the stockholder. In the absence of contrary instructions, or in instances where no specifications
are made, the shares will be voted:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
    the election of two Class III directors to the Board of the Company to serve until the 2024 Annual Meeting of Shareholders.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
    the ratification of Brightman Almagor Zohar &amp; Co., a Member of Deloitte Touche Tohmatsu Limited, or its U.S. affiliate, as the
    Company&rsquo;s independent registered public accounting firm for the year ending December 31, 2021.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    the discretion of the named proxies as to any other matter that may properly come before the Annual Meeting.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
stockholder signing and delivering a proxy may revoke it at any time before it is voted by delivering to the Company&rsquo;s corporate
secretary a written revocation or a duly executed proxy bearing a date later than the date of the proxy being revoked. Any stockholder
attending the Annual Meeting in person may revoke his, her or its proxy and vote his, her or its shares at the Annual Meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>How
to vote shares at our 2021 Annual Meeting.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Voting
at the Annual Meeting</I>. All Company stockholders are invited to attend the Annual Meeting in person. Any stockholder that attends
the meeting in person may deliver a completed proxy card in person or vote by completing a ballot, which will be available at the meeting.
However, each stockholder intending to vote in person at the Annual Meeting should note that if his, her or its shares are held in the
name of a bank, broker or other nominee, such stockholder must obtain a legal proxy, executed in his, her or its favor, from the holder
of record to be able to vote at the Annual Meeting. Stockholders should allow enough time prior to the Annual Meeting to obtain this
proxy from the holder of record, if needed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Whether
you hold shares directly as a registered stockholder of record or beneficially in street name, you may vote without attending the Annual
Meeting. You may vote by granting a proxy or, for shares held in street name, by submitting voting instructions to your broker or nominee.
In most cases, you will be able to do this by telephone, by using the Internet or by mail. Please refer to the summary instructions included
with proxy materials and on your proxy card. For shares held in street name, the voting instruction card will be included in the materials
forwarded by the broker or nominee. If you have telephone or Internet access, you may submit your proxy by following the instructions
with your proxy materials and on your proxy card. You may submit your proxy by mail by signing your proxy card or, for shares held in
street name, by following the voting instructions with your proxy materials and on your proxy card. You may submit your proxy by mail
by signing your proxy card or, for shares held in street name, by following the voting instruction card included in the materials forwarded
by your stockbroker or nominee and mailing it in the enclosed, postage paid envelope. If you provide specific voting instructions, your
shares will be voted as you have instructed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
shares voted electronically or represented by the proxy cards received, properly marked, dated, signed and not revoked, will be voted
at the Annual Meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Quorum,
Required Votes and Method of Tabulation</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consistent
with Delaware law and the Company&rsquo;s amended and restated by-laws, a majority of the votes entitled to be cast on a particular matter,
present in person or represented by proxy, constitutes a quorum as to such matter. Proxies received but marked as &ldquo;ABSTAIN&rdquo;
or &ldquo;WITHHOLD&rdquo;, if any, and broker non-votes (described below), if applicable, will be included in the calculation of the
number of shares considered to be present at the Annual Meeting for quorum purposes. If a quorum is not present, we will be required
to reconvene the Annual Meeting at a later date. The Company will appoint one or more election inspectors for the meeting to count votes
cast by proxy or in person at the Annual Meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you hold shares beneficially in street name and do not provide your broker or nominee with voting instructions, your shares may constitute
&ldquo;broker non-votes.&rdquo; Generally, broker non-votes occur on a matter when a broker is not permitted to vote on that matter without
instructions from the beneficial owner and instructions have not been given. If you hold shares beneficially in street name and do not
vote your shares, your broker or nominee can vote your shares at its discretion on Proposal Number 2. In tabulating the voting result
for any proposal for which the required vote is based on the number of shares present, shares that constitute broker non-votes are not
considered entitled to vote on that proposal. However, for proposals for which the required vote is based on the number of shares of
common stock issued and outstanding, broker non-votes have the same effect as a vote &ldquo;AGAINST&rdquo; the proposal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>What
Vote is Required to Approve Each Item?</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Election
of directors by stockholders, which is Proposal Number 1, will be determined by a plurality of the votes cast by the stockholders entitled
to vote at the election that are either present in person or represented by proxy. Consequently, any shares not voted at the annual meeting,
whether due to abstentions, broker non-votes or otherwise, will have no impact on the election of directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
Proposal Number 2, the affirmative &ldquo;FOR&rdquo; vote is required by the holders of a majority of the votes cast by the stockholders
entitled to vote at the Annual Meeting in person or by proxy and voting. Abstentions and broker non-votes will have no effect on the
outcome of this proposal as they are not considered to be &ldquo;votes cast&rdquo; for purposes of this proposal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
does not know of any matters to be presented at this year&rsquo;s Annual Meeting other than those set forth in this proxy statement and
in the notice accompanying this proxy statement. Stockholders will have no appraisal rights under Delaware law with respect to any of
the matters expected to be voted on at the Annual Meeting. If other matters should properly come before the meeting, the proxy holders
will vote such matters in their discretion. Any stockholder has the right to revoke his, her or its proxy at any time until it is voted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECURITY
OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table shows the number of shares of our common stock beneficially owned, as of August 15, 2021, by (i) each of our directors
and director nominees, (ii) each of our named executive officers, (iii) all of our current directors and executive officers as a group,
and (iv) all those known by us to be to a beneficial owner of more than 5% of the Company&rsquo;s common stock. In general, &ldquo;beneficial
ownership&rdquo; refers to shares that an individual or entity has the power to vote or dispose of, and any rights to acquire common
stock that are currently exercisable or will become exercisable within 60 days of August 15, 2021. We calculated percentage ownership
in accordance with the rules of the SEC. The percentage of common stock beneficially owned is based on 7,108,133 shares outstanding as
of August 15, 2021. In addition, shares issuable pursuant to options or other convertible securities that may be acquired within 60 days
of August 15, 2021 are deemed to be issued and outstanding and have been treated as outstanding in calculating and determining the beneficial
ownership and percentage ownership of those persons possessing those securities, but not for any other persons.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
table is based on information supplied by each director, officer and principal stockholder of the Company. Except as indicated in footnotes
to this table, the Company believes that the stockholders named in this table have sole voting and investment power with respect to all
shares of Common Stock shown to be beneficially owned by them, based on information provided by such stockholders. Unless otherwise indicated,
the address for each director, executive officer and 5% or greater stockholders of the Company listed is: c/o Microbot Medical Inc.,
25 Recreation Park Drive, Unit 108, Hingham, MA 02043.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Beneficial Owner</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of Shares Beneficially Owned</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Percentage of Common Stock Beneficially Owned</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chasing Value Asset Management Inc. <SUP>(1)</SUP></FONT></TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; text-align: right">610,657</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; text-align: right">8.59</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Harel Gadot<SUP>(2)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">495,856</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6.64</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yoseph Bornstein<SUP>(3)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">249,584</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3.51</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scott Burell<SUP>(4)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,236</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Martin Madden<SUP>(4)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,236</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">David Ben Naim<SUP>(4)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prattipati Laxminarain<SUP>(4)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,236</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aileen Stockburger<SUP>(4)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,597</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eyal Morag<SUP>(4)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,875</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tal Wenderow<SUP>(4)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,960</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simon Sharon<SUP>(4)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">19,919</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All current directors and executive officers as a group (10 persons)<SUP>(5)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">811,499</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10.76</TD><TD STYLE="text-align: left">%</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less
    than 1%.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
    on a Schedule 13G filed by the reporting person on January 20, 2021. Sheldon D. Liber is the Chief Executive Officer of the reporting
    person. The address of the principal business office of the reporting person is 2444 Wilshire Boulevard, Suite 300, Santa Monica,
    California 90403.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    (i) 136,847 shares of our common stock owned by MEDX Ventures Group LLC, (ii) 77,846 shares of our common stock issuable upon the
    exercise of options granted to MEDX Ventures Group LLC, and (iii) 281,163 shares of our common stock issuable upon the exercise
    of options granted to Mr. Gadot. Mr. Gadot is the Chief Executive Officer, Company Group Chairman and majority equity owner of MEDX
    Venture Group, LLC and thus may be deemed to share voting and investment power over the shares and options beneficially owned by
    this entity.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    (i) 242,028 shares of our common stock owned by LSA - Life Science Accelerator Ltd. and (ii) 7,556 shares of our common stock
    issuable to Mr. Bornstein upon exercise of options. Based on representations and other information made or provided to the Company
    by Mr. Bornstein, Mr. Bornstein is the CEO and Director of LSA - Life Science Accelerator Ltd. and of Shizim Ltd., and Mr. Bornstein
    is the majority equity owner of Shizim Ltd. Shizim Ltd. is the majority equity owner of LSA - Life Science Accelerator Ltd. Accordingly,
    Mr. Bornstein may be deemed to share voting and investment power over the shares beneficially owned by these entities and has an
    address of 16 Irus Street, Rosh-Ha&rsquo;Ayin Israel 4858022.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    options to acquire shares of our common stock.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    shares of our common stock issuable upon the exercise of options as set forth in footnotes (2), (3) and (4).</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BOARD
OF DIRECTORS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>General</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently have seven directors serving on our Board. The following table lists the names, ages and positions of the individuals who serve
as directors of the Company, as of August 15, 2021:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Age</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Position</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 25%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Harel
    Gadot</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">48</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 66%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President,
    Chief Executive Officer and Chairman of the Board of Directors</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yoseph
    Bornstein(1)(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">63</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scott
    Burell(1)(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">56</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Martin
    Madden(1)(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">61</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prattipati
    Laxminarain(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">64</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aileen
    Stockburger(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">59</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tal
    Wenderow(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Member
    of Audit Committee.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Member
    of Corporate Governance Committee.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Member
    of Compensation Committee.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
we have a classified Board, with each of our directors serving a staggered three-year term, only our Class III Directors are standing
for election at our 2021 Annual Meeting. The following table shows the current composition of the three classes of our Board:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class
I Directors (terms scheduled to expire in 2022):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Harel
    Gadot </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Martin
    Madden</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tal
    Wenderow</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class
II Directors (term scheduled to expire in 2023):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scott
    Burell</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aileen
    Stockburger</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class
III Directors (term scheduled to expire in 2021):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yoseph
    Bornstein (term scheduled to expire in 2021, but nominated to stand for re-election at our 2021 Annual Meeting)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prattipati
    Laxminarain (term scheduled to expire in 2021, but nominated to stand for re-election at our 2021 Annual Meeting)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
independent members of our Board, as determined by the Board in accordance with the existing Nasdaq Listing rules, are Messrs. Bornstein,
Burell, Madden, Laxminarain and Wenderow, and Ms. Stockburger. The Board held approximately nine regular and special meetings during
the fiscal year ended December 31, 2020 and acted by unanimous written consent four times. Each of our then-directors attended all such
meetings of the Board, except on two occasions one director was absent. While we encourage our directors to attend the Company&rsquo;s
annual Shareholder meeting, we do not have a policy requiring that they do so. All of our then-directors attended in person or by telephone
the Company&rsquo;s 2020 annual stockholder meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Committees
of the Board of Directors</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Presently,
the Board has three standing committees &mdash; the Audit Committee, the Compensation and Stock Option Committee (the &ldquo;Compensation
Committee&rdquo;), and the Corporate Governance and Nominating Committee (the &ldquo;Corporate Governance Committee&rdquo;). All members
of the Audit Committee, the Compensation Committee, and the Corporate Governance Committee are, and are required by the charters of the
respective committees to be, independent as determined under Nasdaq Listing rules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Audit
Committee</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Audit Committee is composed of Messrs. Burell, Madden and Bornstein. Each of the members of the Audit Committee is independent, and the
Board has determined that Mr. Burell is an &ldquo;audit committee financial expert,&rdquo; as defined in SEC rules. The Audit Committee
acts pursuant to a written charter which is available through our website at www.microbotmedical.com. The Audit Committee held four meetings
during the fiscal year ended December 31, 2020 and acted by unanimous written consent one time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
primary function of the Audit Committee is to assist the Board of Directors in fulfilling its oversight responsibilities. The Audit Committee
does this primarily by reviewing the Company&rsquo;s financial reports and other financial information as well as the Company&rsquo;s
systems of internal controls regarding finance, accounting, legal compliance, and ethics that management and the Board of Directors have
established. The Audit Committee also assesses the Company&rsquo;s auditing, accounting and financial processes more generally. The Audit
Committee recommends to the Board of Directors the appointment of a firm of independent auditors to audit the financial statements of
the Company and meets with such personnel of the Company to review the scope and the results of the annual audit, the amount of audit
fees, the company&rsquo;s internal accounting controls, the Company&rsquo;s financial statements contained in this proxy statement, and
other related matters</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Compensation
Committee</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Compensation Committee is composed of Messrs. Madden (Chairman), Bornstein and Stockburger. Each of the members of the Compensation Committee
is independent. The Compensation Committee acts pursuant to a written charter which is available through our website at www.microbotmedical.com.
The Compensation Committee held 11 meetings during the fiscal year ended December 31, 2020 and acted by unanimous written consent two
times.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Compensation Committee acts pursuant to a written charter. The Compensation Committee makes recommendations to the Board of Directors
and management concerning salaries in general, determines executive compensation and approves incentive compensation for employees and
consultants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Corporate
Governance Committee</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Corporate Governance Committee is composed of Messrs. Laxminarain, Burell and Wenderow. Each of the members of the Corporate Governance
Committee is independent. The Corporate Governance Committee acts pursuant to a written charter which is available through our website
at www.microbotmedical.com. The Corporate Governance Committee acted by unanimous written consent two times during the fiscal year ended
December 31, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Corporate Governance Committee oversees nominations to the Board and considers the experience, ability and character of potential nominees
to serve as directors, as well as particular skills or knowledge that may be desirable in light of the Company&rsquo;s position at any
time. From time to time, the Corporate Governance Committee may engage the services of a paid search firm to help the Corporate Governance
Committee identify potential nominees to the Board. The Corporate Governance Committee and Board seek to nominate and appoint candidates
to the Board who have significant business experience, technical expertise or personal attributes, or a combination of these, sufficient
to suggest, in the Board&rsquo;s judgment, that the candidate would have the ability to help direct the affairs of the Company and enhance
the Board as a whole. The Corporate Governance Committee may identify potential candidates through any reliable means available, including
recommendations of past or current members of the Board from their knowledge of the industry and of the Company. The Corporate Governance
Committee also considers past service on the Board or on the board of directors of other publicly traded or technology focused companies.
The Corporate Governance Committee has not adopted a formulaic approach to evaluating potential nominees to the Board; it does not have
a formal policy concerning diversity, for example. Rather, the Corporate Governance Committee weighs and considers the experience, expertise,
intellect, and judgment of potential nominees irrespective of their race, gender, age, religion, or other personal characteristics. The
Corporate Governance Committee may look for nominees that can bring new skill sets or diverse business perspectives. Potential candidates
recommended by security holders will be considered as provided in the company&rsquo;s &ldquo;Policy Regarding Shareholder Candidates
for Nomination as a Director,&rdquo; which sets forth the procedures and conditions for such recommendations. This policy is available
through our website at www.microbotmedical.com.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
members of the Corporate Governance Committee have approved the nomination of the Class III directors standing for election or reelection,
as the case may be, at our 2021 Annual Meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Director
Oversight and Qualifications</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">While
management is responsible for the day-to-day management of the risks the company faces, the Board, as a whole and through its committees,
has responsibility for the oversight of risk management. An important part of risk management is not only understanding the risks facing
the company and what steps management is taking to manage those risks, but also understanding what level of risk is appropriate for the
company. In support of this oversight function, the Board receives regular reports from our Chief Executive Officer and members of senior
management on operational, financial, legal, and regulatory issues and risks. The Audit Committee additionally is charged under its charter
with oversight of financial risk, including the company&rsquo;s internal controls, and it receives regular reports from management, the
company&rsquo;s internal auditors and the company&rsquo;s independent auditors. The chairman of the Board and independent members of
the Board work together to provide strong, independent oversight of the company&rsquo;s management and affairs through its standing committees
and, when necessary, special meetings of directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">We
believe each of our directors brings valuable skills, experience, judgment, and perspectives to our company. The Board took the following
qualifications into consideration, among other things, when nominating or appointing our current directors:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Harel
Gadot</I><FONT STYLE="background-color: white">, became President, Chief Executive Officer and Chairman of the Company&rsquo;s Board
following the consummation of the merger of C&amp;RD Israel Ltd, a wholly owned subsidiary of the Company, with and into Microbot Medical
Ltd. (&ldquo;Microbot Israel&rdquo;), with Microbot Israel surviving as a wholly owned subsidiary of the Company (the &ldquo;Merger&rdquo;).
Mr. Gadot is a co-founder of Microbot Israel and has served as Microbot Israel&rsquo;s Chief Executive Officer since Microbot Israel
was founded in November 2010. He has been the Chairman of Microbot Israel&rsquo;s board of directors since July 2014. He also serves
as the Chairman of XACT Robotics Ltd., an Israel-based private company seeking to develop a novel platform technology for robotic needle
steering in minimally invasive interventional procedures such as biopsies and ablations, since August 2013 and MEDX Xelerator L.P., a
medical device and digital health Israeli incubator, since July 2016. From December 2007 to April 2010 Mr. Gadot was a Worldwide Group
Marketing Director at Ethicon Inc., a Johnson and Johnson Company, where he was responsible for the global strategic marketing of the
Company. Mr. Gadot also held management positions, as well as leading regional strategic position for Europe, Middle-East and Africa,
as well as In Israel, while at Johnson and Johnson. Mr. Gadot served as director for ConTIPI Ltd. from August 2010 until November 2013
when ConTIPI Ltd. was acquired by Kimberly-Clark Corporation. Mr. Gadot holds a B.Sc. in Business from Siena College, Loudonville NY,
and an M.B.A. from the University of Manchester, UK. The Company believes that Mr. Gadot is qualified to serve as Chairman of the Board
and as President and Chief Executive Officer of the Company due to his extensive experience in strategic marketing and general management
in the medical device industry.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Yoseph
Bornstein</I><FONT STYLE="background-color: white">, became a director of the Company following the Merger. Mr. Bornstein is a co-founder
of Microbot Israel and has been a member of the Board of Directors since Microbot Israel was founded in November 2010. Mr. Bornstein
founded Shizim Ltd., a life science holding group in October 2000 and has served as its president since then. Mr. Bornstein is the Chairman
of GCP Clinical Studies Ltd., a provider of clinical research services and educational programs in Israel since January 2002. He is the
Chairman of Biotis Ltd., a service company for the bio-pharmaceutical industry, since June 2000. In addition, he is the Chairman of Dolphin
Medical Ltd., which supplies the medical device industry, since April 2012, and the Chairman of ASIS Enterprises B.B.G. Ltd., a business
development company focusing on creating business ties between Israeli and Japanese entities, since August 2007. Mr. Bornstein is a co-founder
and director of XACT Robotics, which is developing a novel platform technology for robotic needle steering in minimally invasive interventional
procedures. In October 1992, Mr. Bornstein founded Pharmateam Ltd., an Israeli company that specialized in representing international
pharmaceutical companies which was sold in 2000. Mr. Bornstein is also a founder of a number of other privately held life-science companies.
Mr. Bornstein served as the Biotechnology Committee Chairman of the Unites States-Israel Science &amp; Technology Commission (the &ldquo;USISTC&rdquo;)
from September 2002 to February 2005 as well as a consultant for USISTC from September 2002 to February 2005. He is also the founder
of ILSI-Israel Life Science Industry Organization (who was integrated into IATI) and ITTN-Israel Tech Transfer Organization. He founded
in July 2014 ShizimXL Ltd., an international medical device innovation center, and founded in January 2020 ShizimVS Ltd., a digital health
innovation center. Mr. Bornstein was nominated in August 2021 to be an external director in Can-fit BioPharma Ltd. (Nasdaq:CANF). The
Company believes that Mr. Bornstein is qualified to serve as a member of the Board due to his extensive experience in, and knowledge
of, the life sciences industry and international business.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><I>Scott
R. Burell</I>, became a director of the Company following the Merger. Since August 1, 2018, Mr. Burell has been the Chief Financial Officer
of AIVITA Biomedical, Inc., an Irvine California-based immuno-oncology company focused on the advancement of commercial and clinical-stage
programs utilizing curative and regenerative medicines. From November 2006 until its sale to Invitae Corp. (NYSE: NVTA) in November 2017,
he was the Chief Financial Officer, Secretary and Treasurer of CombiMatrix Corporation (NASDAQ: CBMX), a family health-focused clinical
molecular diagnostic laboratory specializing in pre-implantation genetic screening, prenatal diagnosis, miscarriage analysis, and pediatric
developmental disorders. He successfully led the split-off of CombiMatrix in 2007 from its former parent, has led several successful
public and private debt and equity financing transactions as well as CombiMatrix&rsquo;s reorganization in 2010. Prior to this, Mr. Burell
had served as CombiMatrix&rsquo;s Vice President of Finance since November 2001 and as its Controller from February 2001 to November
2001. From May 1999 to first joining CombiMatrix in February 2001, Mr. Burell was the Controller for Network Commerce, Inc. (NASDAQ:
SPNW), a publicly traded technology and information infrastructure company located in Seattle. Prior to this, Mr. Burell spent nine years
with Arthur Andersen&rsquo;s Audit and Business Advisory practice in Seattle. During his tenure in public accounting, Mr. Burell worked
with many clients, both public and private, in the high-tech and healthcare markets, and was involved in numerous public offerings, spin-offs,
mergers and acquisitions. Mr. Burell obtained his Washington state CPA license in 1992 and is a certified public accountant (currently
inactive). He holds Bachelor of Science degrees in Accounting and Business Finance from Central Washington University. The Company believes
Mr. Burell&rsquo;s qualifications to serve on the Board include his experience as an executive of a public life sciences company and
knowledge of financial accounting in the medical technology field.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><I>Martin
Madden</I>, has been a director of the Company since February 6, 2017. Mr. Madden has held various positions at Johnson &amp; Johnson
and its affiliates from 1986 to January 2017, most recently as Vice President, Research &amp; Development of DePuy Synthes, a Johnson
&amp; Johnson Company, from February 2016 to January 2017. Prior to that, from July 2015 to February 2016, Mr. Madden was the Vice President,
New Product Development of Johnson &amp; Johnson Medical Devices. From January 2012 to July 2015, Mr. Madden was the Vice President,
Research &amp; Development of Johnson &amp; Johnson&rsquo;s Global Surgery Group. During his thirty-year tenure with Johnson &amp; Johnson&rsquo;s
Medical Device organization, he was an innovator and research leader for nearly every medical device business including Cardiology, Electrophysiology,
Peripheral Vascular Surgery, General and Colorectal Surgery, Aesthetics, Orthopaedics, Sports Medicine, Spine, and Trauma. As an executive
of Johnson &amp; Johnson, Mr. Madden served on the management boards of Johnson &amp; Johnson&rsquo;s Global Surgery Group, Ethicon,
Ethicon Endo-Surgery, DePuy-Synthes, and Cordis, with responsibility for research and development &ndash; inclusive of organic and licensed/acquired
technology. He was also Chairman of J&amp;J&rsquo;s Medical Device Research Council, with responsibility for talent strategy and technology
acceleration. Mr. Madden serves on the Board of Directors of Novocure (NASDAQ: NVCR), a global oncology company, and is an advisor to
numerous medical device start-ups. Mr. Madden holds a MBA from Columbia University, a M.S. from Carnegie Mellon University in Mechanical
Engineering, and a B.S. from the University of Dayton in Mechanical Engineering. The Company believes that Mr. Madden is qualified to
serve as a member of the Board due to his extensive experience in research and development, portfolio planning, technology assessment
and assimilation, and project management and budgeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><I>Prattipati
Laxminarain</I>, has been a director of the Company since December 6, 2017. From April 2006 through October 2017, Mr. Laxminarain served
as Worldwide President at Codman Neuro, a global neurosurgery and neurovascular company that offers a portfolio of devices for hydrocephalus
management, neuro intensive care and cranial surgery and other technologies, and which was part of DePuy Synthes Companies of Johnson
&amp; Johnson. Mr. Laxminarain is currently the CEO of Deinde Medical Corporation, and is a Board Member of Oculogica Inc., Millar Inc.,
and GT Medical Inc. He has a degree in Mechanical Engineering from Osmania University, Hyderabad, India and an MBA from Indian Institute
of Management. The Company believes that Mr. Laxminarain is qualified as a Board member of the Company because of his extensive experience
working with medical device companies and knowledge of the industries in which the Company intends to compete.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Aileen
Stockburger</I> was appointed by the Board on March 26, 2020 to fill a vacancy on the Board and to serve as a Class II director of the
Company, with a term commencing on April 1, 2020. Since February 2018, Ms. Stockburger has provided M&amp;A consulting and advisory services
through Aileen Stockburger LLC. Prior to that, from 1989 through January 2018, Ms. Stockburger held various positions in Johnson &amp;
Johnson, most recently as Vice President, Worldwide Business Development &amp; Strategic Planning for the DePuy Synthes Group of Johnson
&amp; Johnson, and as a member of its Worldwide Board and Group Operating Committee, from 2010-2018. In that role, she oversaw the group&rsquo;s
merger and acquisition activities, including deal structuring, negotiations, contract design and review, and deal terms. Before joining
Johnson &amp; Johnson, Ms. Stockburger spent several years at PriceWaterhouseCoopers, and earned her CPA certification. She is also a
Non-Executive Director of Next Science Limited (ASX: NXS), a medical technology company headquartered in Sydney, Australia, with a primary
focus in the development and continued commercialization of its proprietary technology to reduce the impact of biofilm based infections
in human health. She also serve on the Audit Committee and the People, Culture and Remuneration Committee of the Board of Directors of
Next Science Limited. Ms. Stockburger received her MBA and BS from The Wharton School, University of Pennsylvania. The Company believes
that Ms. Stockburger is qualified as a Board member of the Company because of her extensive experience in strategizing, managing and
closing sizable, complex worldwide mergers and acquisitions, licensing agreements and divestitures, as well as her expertise in business
development, strategic planning and finance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Tal
Wenderow</I> was appointed by the Board on July 29, 2020 to fill a vacancy on the Board and to serve as a Class I director of the Company,
with a term commencing on August 1, 2020. Since February 2019, Mr. Wenderow serves as the President and CEO of Vocalis Health Inc., an
AI healthtech company pioneering the development of vocal biomarkers. Previously, Mr. Wenderow co-founded Corindus Vascular Robotics
in 2002, which was a New York Stock Exchange-listed company upon its acquisition by Siemens Healthineers in 2019. Mr. Wenderow held various
positions at Corindus from founder, Chief Executive Officer and director at inception, Executive Vice President Product &amp; Business
Development to his most recent role as Executive Vice President of International &amp; Business Development. Mr. Wenderow received a
B.Sc. in Mechanical Engineering at the Technion &ndash; Israel Institute of Technology, Haifa, Israel. The Company believes that Mr.
Wenderow is qualified as a Board member of the Company because of his extensive knowledge of the medical robotics space with specific
focus on interventional procedures, as well as his medical devices start up experience.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Executive
Officers</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
are the name, age and other information for our executive officers, as of August 15, 2021. All company officers have been appointed to
serve until their successors are elected and qualified or until their earlier resignation or removal. Information regarding Harel Gadot,
our Chairman, President and Chief Executive Officer, is set forth above under &ldquo;Board of Directors.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Age</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Position</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 27%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Harel
    Gadot</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 7%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">48</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 62%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President,
    Chief Executive Officer and Chairman of the Board of Directors</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">David
    Ben Naim</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">52</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simon
    Sharon</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">62</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Technology Officer and General Manager, Microbot Israel</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eyal
    Morag</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">56</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Medical Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>David
Ben Naim</I><FONT>, became the Company&rsquo;s part-time Chief Financial Officer following the consummation
of the Merger. Mr. Ben Naim is the general manager of DBN Finance Services Ltd., a company which provides outsourcing financial services
to public and private companies, since 2014, including the Company. Through DBN Finance Services, Mr. Ben Naim has acted as the outsourced
CFO for Emerald Medical Applications Corp. (OTC:MRLA), a digital health startup company engaged in the development, sale and service
of imaging solutions, Tempramed Inc., a private medical device company, Vonetize PLC (TASE:VNTZ), an Israeli company that offers video
on demand and over-the-top content services, Unet Credit Finance Services Ltd. (TASE:UNCR-M), Todos Medical Ltd. (OTC:TOMDF), an Israeli
cancer in-vitro-diagnostic company engaging in the development of a series of blood tests for the early detection of a variety of cancers
and 3DM Digital Manufacturing Ltd. (TASE:3DM), an Israeli company which operates in the field of plastic polymers industrial 3D printing.
Prior to that, Mr. Ben Naim served as Chief Financial Officer for several companies in the biomedical and technology industries.
From July 2012 to September 2014, Mr. Ben Naim served as Chief Financial Officer for Insuline Medical Ltd. (TASE: INSL), an Israel-based
company focused on improving performance of insulin treatment methods. From 2008 until 2011, Mr. Ben Naim served as Chief Financial Officer
of Crow Technologies 1977 Ltd. (OTC:CRWTF), a company that designs, develops, manufactures and sells a broad range of security and alarm
systems. From 2007 to 2008, Mr. Ben Naim served as Chief Financial Officer of Ilex Medical Ltd. (TASE:ILX), a leading company in the
medical diagnostics field. From 2003 to 2007, Mr. Ben Naim was the Corporate Controller of Tadiran Telecom Ltd. He started his career
in 1998 at Deloitte &amp; Touche where he left in 2003 as an Audit Senior Manager. Mr. Ben Naim holds a B.A. in social sciences from
Open University, Israel, a CPA license from Ramat Gan College, Israel, and an M.B.A. from Ono Academic College, Israel.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Simon
Sharon</I>, has served as the Company&rsquo;s Chief Technology Officer since April 2018 and as the General Manager of Microbot Israel
since April 2021. From August 2016 to March 2018, Mr. Sharon served as the Chief Technology Officer at MEDX Xelerator, an Israel-based
medical device and digital health incubator. He is also a director of XACT Robotics Ltd., a private Israeli company developing a novel
platform robotic technology for needle steering in minimally invasive interventional procedures. Mr. Harel Gadot, the Company&rsquo;s
President, CEO and Chairman, is the Chairman of each of XACT and MEDX Xelerator. Prior to this, Mr. Sharon held the position of Chief
Operating Officer at Microbot Israel before it became a publicly traded company from February 2013 to August 2016. Prior to joining Microbot
Israel, Mr. Sharon was the Vice President of Research &amp; Development with IceCure Medical, a TASE traded company developing a portfolio
of cryogenic ablation systems. Prior to IceCure, he held roles of increasing responsibility at Rockwell Automation&ndash;Anorad Israel
Ltd., a leading linear motor-based, precision positioning equipment manufacturer. Prior to Rockwell, Mr. Sharon was the Research &amp;
Development Manager at Disc-O-Tech Medical Technologies Ltd., a private orthopedic venture that was acquired by Kyphon (currently part
of Medtronic), and before this was the Research &amp; Development Manager at CI Systems, a worldwide supplier of a wide range of electro-optical
test and measurement equipment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><I>Eyal
Morag</I>, has </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">served as the Company&rsquo;s Chief Medical
Officer (&ldquo;CMO&rdquo;) since May 2020<FONT STYLE="background-color: white">. As CMO, Dr. Morag leads the development and execution
of the clinical strategy of the Company, including its current development of the SCS and LIBERTY products as well as its future pipeline.
Dr. Morag is a member of the Company&rsquo;s Scientific Advisory Board since November 1, 2017. Dr. Morag is certified by the American
Board of Radiology, and from March 2017 through May 2020 has been the Chairman of Radiology at Assuta Ashdod Medical Center, Ashdod,
Israel. Previously, from July 2014 through March 2017, he was the senior Radiologist at URG Teleradiology LLC, the largest provider of
subspecialty radiology and teleradiology services in New Jersey. He is a graduate of Boston University School of Medicine and completed
both his Radiology residency and Fellowship in Cardiovascular &amp; Interventional Radiology at the Beth Israel Deaconess Medical Center
&amp; Harvard Medical School. Following his clinical training, Dr. Morag then joined a private practice in western Massachusetts, where
he served as Chief of Radiology at Holyoke Medical Center for several years. He has also served as the Regional Radiology Director at
Mercy Health Partners Hospitals in Toledo, Ohio, and was a member of the University Radiology Group where he headed the International
Investment efforts for the Ventures division. Dr. Morag&rsquo;s international experience developing and establishing radiology-related
businesses includes teleradiology, interventional Radiology services, and free-standing imaging centers. During his fellowship, Dr. Morag
co-founded InTek Technology, a medical device startup company. Later he founded Global Versa Radiology (&ldquo;GVR&rdquo;), an Israeli
and U.S. based teleradiology company. GVR has established imaging centers in Russia and Ukraine and provided teleradiology services in
countries outside the U.S. and Israel. Dr. Morag served as GVR&rsquo;s Chief Medical Officer and Vice-President. He continues to be involved
in several startup companies ranging from AI to medical devices. Dr. Morag is also a member of the Advisory Board of MEDX Xelerator,
a medical device and digital health incubator, of which Mr. Gadot is Chairman.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Section
16(a) Beneficial Ownership Reporting Compliance</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Section
16(a) of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;), requires our executive officers, directors,
and persons who own more than 10% of a registered class of our equity securities, to file with the SEC reports of ownership of our securities
and changes in reported ownership. Executive officers, directors and greater than 10% beneficial owners are required by SEC rules to
furnish us with copies of all Section 16(a) reports they file. Based solely on a review of the copies of such forms furnished to us,
or written representations from the reporting persons that no Form 5 was required, we believe that, during the fiscal year ended December
31, 2020, all Section 16(a) filing requirements applicable to our officers, directors and greater than 10% beneficial owners have been
met, except Mr. Wenderow was delinquent on one Form 3 and on one Form 4 relating to a single transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Code
of Business Conduct and Ethics</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have adopted a Code of Ethics and Conduct that applies to all of our directors, officers, employees, and consultants. A copy of our code
of ethics is posted on our website at www.microbotmedical.com. We intend to disclose any substantive amendment or waivers to this code
on our website. There were no substantive amendments or waivers to this code in 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXECUTIVE
COMPENSATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Summary
Compensation Table</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth information regarding each element of compensation that was paid or awarded to the named executive officers
of the Company for the periods indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Name and Principal Position</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Salary ($)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Bonus ($)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Stock Awards ($)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Option Awards ($) (1)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Non-Equity Incentive Plan Compensation ($)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">All Other Compensation ($)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0; margin-bottom: 0">Total</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">($)</P></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 28%; font-weight: bold; text-align: left">Harel Gadot</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%; text-align: right">2020</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%; text-align: right">450,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%; text-align: right">270,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%; text-align: right">&ndash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%; text-align: right">1,622,446</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%; text-align: right">&ndash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%; text-align: right">13,800</TD><TD STYLE="width: 1%; text-align: left">(2)</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%; text-align: right">2,356,246</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">CEO, President &amp; Chairman</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2019</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">360,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">144,000</TD><TD STYLE="text-align: left">(3)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">482,493</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13,800</TD><TD STYLE="text-align: left">(2)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,000,293</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold">Eyal Morag(4)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2020</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">243,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">21,622</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,079</TD><TD STYLE="text-align: left">(5)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">271,701</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Chief Medical Officer</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2019</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">David Ben Naim</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2020</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">82,242</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,308</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">102,550</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Chief Financial Officer</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2019</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">74,268</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,308</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">94,576</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts
    shown do not reflect cash compensation actually received by the named executive officer. Instead, the amounts shown are the non-cash
    aggregate grant date fair values of stock option awards made during the periods presented as determined pursuant to ASC Topic 718
    and excludes the effect of forfeiture assumptions. The assumptions used to calculate the fair value of stock option awards are set
    forth under Note 9 to the Consolidated Financial Statements of the Company included in the Annual Report.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    Other Compensation includes Mr. Gadot&rsquo;s monthly automobile allowance and tax gross-up.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    Mr. Gadot&rsquo;s bonus for the 2019 fiscal year, which amount was actually paid in 2020.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Morag commence employment on May 1, 2020. Dr. Morag entered into an Employment Agreement with the Company as of February 18, 2020.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    Other Compensation includes Dr. Morag&rsquo;s yearly automobile allowance.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Outstanding
Equity Awards at Fiscal Year-End</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents the outstanding equity awards held by each of the named executive officers as of the end of the fiscal year
ended December 31, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&nbsp;</TD><TD COLSPAN="14" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font-weight: bold">Option Awards</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="14" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Stock Awards</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Name</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of Securities Underlying Unexercised Options Exercisable</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of Securities Underlying Unexercised Options Unexercisable</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Option Exercise Price</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Option Expiration Date</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of Shares or Units of Stock That Have Not Vested</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Market value of Shares of Units of Stock That Have Not Vested</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights That Have Not Vested</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 10%; text-align: left">Harel Gadot</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">77,846</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">&ndash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right">4.20</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 10%; text-align: right">1/01/2025</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; text-align: right">&ndash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; text-align: right">&ndash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; text-align: right">&ndash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; text-align: right">&ndash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">108,148</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12,699</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15.75</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">9/14/2027</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">166,666</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9.64</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">2/25/2030</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Eyal Morag</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,250</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">18,750</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6.16</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">7/14/2030</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">David Ben Naim</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15.30</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">12/28/2027</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Executive
Employment Agreements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Harel
Gadot Employment Agreement</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company entered into an employment agreement (the &ldquo;Gadot Agreement&rdquo;) with Harel Gadot on November 28, 2016, to serve as the
Company&rsquo;s Chairman of the Board of Directors and Chief Executive Officer, on an indefinite basis subject to the termination provisions
described in the Agreement. Pursuant to the terms of the Gadot Agreement, as amended most recently on February 25, 2020, Mr. Gadot shall
receive an annual base salary of $450,000. The salary is reviewed on an annual basis by the Compensation Committee of the Company to
determine potential increases taking into account such performance metrics and criteria as established by Mr. Gadot and the Company.
Accordingly, for the 2021 fiscal year, Mr. Gadot&rsquo;s annual base salary was increased to $500,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
as of January 1, 2020, Mr. Gadot shall also be entitled to receive a target annual cash bonus of up to a maximum amount of 60% of base
salary, which maximum amount was paid for the 2020 fiscal year. In addition, Mr. Gadot received in February 202 a one-time special bonus
equal to $270,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Gadot shall be further entitled to a monthly automobile allowance and tax gross up on such allowance of $1,150, and shall be granted
options to purchase shares of common stock of the Company representing 5% of the issued and outstanding shares of the Company, based
on vesting and other terms to be determined by the Compensation Committee of the Board of Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event Mr. Gadot&rsquo;s employment is terminated as a result of death, Mr. Gadot&rsquo;s estate would be entitled to receive any
earned annual salary, bonus, reimbursement of business expenses and accrued vacation, if any, that is unpaid up to the date of Mr. Gadot&rsquo;s
death.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event Mr. Gadot&rsquo;s employment is terminated as a result of disability, Mr. Gadot would be entitled to receive any earned annual
salary, bonus, reimbursement of business expenses and accrued vacation, if any, incurred up to the date of termination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event Mr. Gadot&rsquo;s employment is terminated by the Company for cause, Mr. Gadot would be entitled to receive any compensation
then due and payable incurred up to the date of termination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event Mr. Gadot&rsquo;s employment is terminated by the Company without cause, he would be entitled to receive (i) any earned annual
salary; (ii) 12 months&rsquo; pay and full benefits, (iii) a pro rata bonus equal to the maximum target bonus for that calendar year;
(iv) the dollar value of unused and accrued vacation days; and (v) applicable premiums (inclusive of premiums for Mr. Gadot&rsquo;s dependents)
pursuant to the Consolidated Omnibus Budget Reconciliation Act of 1986, as amended, for twelve (12) months from the date of termination
for any benefits plan sponsored by the Company. In addition, 100% of any unvested portion of his stock options shall immediately vest
and become exercisable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
agreement contains customary non-competition and non-solicitation provisions pursuant to which Mr. Gadot agrees not to compete and solicit
with the Company. Mr. Gadot also agreed to customary terms regarding confidentiality and ownership of intellectual property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>David
Ben Naim Services Agreement</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
entered into a services agreement (the &ldquo;Services Agreement&rdquo;) with DBN Finance Services effective October 31, 2016, to provide
outsourced CFO services. Pursuant to the terms of the Services Agreement, DBN Finance Services will provide its services exclusively
through Mr. David Ben Naim, who will serve as the principal financial and accounting officer of Microbot Israel and the Company. Mr.
Ben Naim&rsquo;s engagement will continue on an indefinite basis subject to the termination provisions described in the Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Agreement, the Company shall pay the Service Provider a fixed fee of NIS 22,000, or the equivalent of approximately $6,380 per
month based on an exchange rate of $.29 for NIS1.0, plus VAT per month, and the Company shall reimburse DBN Finance Services for reasonable
and customary out of pocket expenses incurred by it or Mr. Ben Naim connection with the performance of the duties under the Services
Agreement. In addition, the Company shall maintain for the benefit of Mr. Ben Naim, a Directors and Officers insurance policy, according
to the Company&rsquo;s policy for other directors and officers of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Both
the Company and DBN Finance Services shall have the right to terminate the Agreement for any reason or without reason at any time by
furnishing the other party with a 30-day notice of termination. The Company shall further be entitled to terminate the Services Agreement
for &ldquo;cause&rdquo; without notice, in which case neither DBN Finance Services nor Mr. Ben Naim shall be entitled to any compensation
due to such early termination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DBN
Finance Services and Mr. Ben Naim agreed to customary provisions regarding confidentiality and intellectual property ownership. The Services
Agreement also contains customary non-competition and non-solicitation provisions pursuant to which DBN Finance Services and Mr. Ben
Naim agree not to compete and solicit with the Company during the term of the Agreement and for a period of twelve months following the
termination of the Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Simon
Sharon Employment Agreement</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company entered into an employment agreement, dated as of March 31, 2018 and amended pursuant to a First Amendment to Employment Agreement
dated as of April 19, 2021 (as so amended, the &ldquo;Sharon Agreement&rdquo;), with Mr. Sharon, to serve as the Company&rsquo;s Chief
Technology Officer and the General Manager of Microbot Israel, on an indefinite basis subject to the termination provisions described
in the Sharon Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the terms of the Sharon Agreement, Mr. Sharon receives a combined base salary and overtime payment of NIS72,000 per month. Mr. Sharon
is also entitled to receive an annual cash bonus of up to 35% of the combined salary and overtime payment, based on certain performance
factors established and assessed by the Compensation Committee of the Board of Directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Sharon shall be further entitled to a monthly automobile allowance plus a tax gross up to cover taxes relating to the grant of such motor
vehicle, and pursuant to the Sharon Agreement was initially granted options in 2018 to purchase 150,000 shares (pre-stock split) of common
stock of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Sharon Agreement, the Company pays to (unless agreed otherwise by the parties) an insurance company or a pension fund, for Mr.
Sharon, an amount equal to 8.33% of the base salary and overtime payments, which shall be allocated to a fund for severance pay, and
an additional amount equal to 6.5% of the base salary and overtime payments, which shall be allocated to a provident fund or pension
plan. The Company also pays an additional sum for disability insurance to insure Mr. Sharon for up to 75% of base salary and overtime
payments, and 7.5% of each monthly payment to be allocated to an educational fund.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Either
the Company or Mr. Sharon may terminate the Sharon Agreement without cause (as defined in the Sharon Agreement) by providing the other
party with ninety days prior written notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company may terminate the Sharon Agreement for cause at any time by written notice without any advance notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sharon Agreement contains customary non-competition and non-solicit provisions pursuant to which Mr. Sharon agrees not to compete and
solicit with the Company. Mr. Sharon also agreed to customary terms regarding confidentiality and ownership of intellectual property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Eyal
Morag Employment Agreement</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
entered into an employment agreement (the &ldquo;Morag Agreement&rdquo;), as of February 18, 2020, with Dr. Morag, to serve as the Company&rsquo;s
Chief Medical Officer, on an indefinite basis subject to the termination provisions described in the Morag Agreement. Pursuant to the
terms of the Morag Agreement, Dr. Morag shall receive a base salary of NIS64,000 per month plus Global Overtime (as defined in the Morag
Agreement) of NIS 16,000 per month.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
Morag shall also be entitled to receive a target annual cash bonus, based on certain milestones, of up to a maximum amount of 30% of
his annual salary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
Morag shall be further entitled to a monthly automobile allowance not to exceed NIS 4,800 per month plus expenses and applicable taxes,
and shall be granted options to purchase 25,000 shares of common stock of the Company based on vesting and other terms set forth in the
Morag Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Morag Agreement, the Company shall pay an amount equal to 8.33% of Dr. Morag&rsquo;s salary to be allocated for severance pay,
6.5% of Dr. Morag&rsquo;s salary to be allocated for pension savings and 7.5% to be allocated to an educational fund. The Company may
have additional payment obligations for disability insurance as specified in the Morag Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the initial 24 months following the Commencement Date (&ldquo;Initial Period&rdquo;), either the Company or Dr. Morag may terminate the
Morag Agreement at its discretion at any time by providing the other party with a three months (or, following the Initial Period, six
months) prior written notice of termination (the &ldquo;Advance Notice Period&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company may terminate the Morag Agreement &ldquo;For Cause&rdquo; (as defined in the Morag Agreement) at any time by written notice without
the Advance Notice Period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event that the Company terminates Dr. Morag&rsquo;s employment during the Initial Period other than For Cause, Dr. Morag shall be
entitled to a one-time payment in an amount equal to his annual salary as of the date of termination of employment multiplied by the
balance time between the end of the Advance Notice Period and until the end of the Initial Period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Morag Agreement contains customary non-competition and non-solicit provisions pursuant to which Dr. Morag agrees not to compete and solicit
with the Company. Dr. Morag also agreed to customary terms regarding confidentiality and ownership of intellectual property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Indemnification
Agreements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Company generally enters into indemnification agreements with each of its directors and executive officers. Pursuant to the indemnification
agreements, the Company has agreed to indemnify and hold harmless these current and former directors and officers to the fullest extent
permitted by the Delaware General Corporation Law. The agreements generally cover expenses that a director or officer incurs or amounts
that a director or officer becomes obligated to pay because of any proceeding to which he is made or threatened to be made a party or
participant by reason of his service as a current or former director, officer, employee or agent of the Company, provided that he acted
in good faith and in a manner he reasonably believed to be in or not opposed to the best interests of the Company. The agreements also
provide for the advancement of expenses to the directors and officers subject to specified conditions. There are certain exceptions to
the Company&rsquo;s obligation to indemnify the directors and officers, and, with certain exceptions, with respect to proceedings that
he initiates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Limits
on Liability and Indemnification</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
provide directors and officers insurance for our current directors and officers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
certificate of incorporation eliminate the personal liability of our directors to the fullest extent permitted by law. The certificate
of incorporation further provide that the Company will indemnify its officers and directors to the fullest extent permitted by law. We
believe that this indemnification covers at least negligence on the part of the indemnified parties. Insofar as indemnification for liabilities
under the Securities Act may be permitted to our directors, officers, and controlling persons under the foregoing provisions or otherwise,
we have been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed
in the Securities Act of 1933 and is therefore unenforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Director
Compensation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company adopted in January 2021 an amended compensation package for the non-management members of its Board, pursuant to which each such
Board member would receive for his or her services $35,000 per annum. Furthermore, each member of the Audit Committee of the Board receives
an additional $10,000 per annum ($20,000 if Chairman), each member of the Compensation Committee of the Board receives an additional
$7,500 per annum ($15,000 if Chairman) and each member of the Corporate Governance and Nominating Committee of the Board receives an
additional $5,000 per annum ($10,000 if Chairman). Board members are also entitled to receive equity awards. Upon joining the Board,
a member would receive an initial grant of $190,000 of stock options (calculated as the product of the exercise price on the date of
grant multiplied by the number of shares underlying the stock option award required to equal $190,000), with an additional grant of stock
options each year thereafter, to purchase such number of shares of the Company&rsquo;s common stock equal to $95,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes cash-based and equity compensation information for our outside directors, including annual Board and committee
retainer fees and meeting attendance fees, for the year ended December 31, 2020:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Name</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Fees earned or paid in cash</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Stock Awards</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Option Awards (1)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Non-Equity Incentive Plan Compensation</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Nonqualified Deferred Compensation Earnings</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">All Other Compensation</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 28%; text-align: left">Yoav Waizer (2)</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">24,250</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">11,550</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 3%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 3%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 3%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">35,800</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Yoseph Bornstein</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">38,750</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">22,895</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">61,645</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Scott Burell</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">41,250</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">22,895</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">64,145</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Martin Madden</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">38,750</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">22,895</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">61,645</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Prattipati Laxminarain</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">29,750</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">22,895</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">52,645</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Aileen Stockburger</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">13,250</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">5,123</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">18,373</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Tal Wenderow</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">9,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">4,484</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">13,984</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 95%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts
    shown do not reflect cash compensation actually received by the director. Instead, the amounts shown are the non-cash aggregate grant
    date fair values of stock option awards made during the period presented as determined pursuant to ASC Topic 718 and excludes the
    effect of forfeiture assumptions. The assumptions used to calculate the fair value of stock option awards are set forth under Note
    9 to the Consolidated Financial Statements of the Company included in the Annual Report.</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Waizer resigned as a director of the Company effective as of June 30, 2020.</FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Mr.
Gadot received compensation for his services to the Company as set forth under the summary compensation table above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTAIN
RELATIONSHIPS AND RELATED TRANSACTIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Related
parties can include any of our directors or executive officers, certain of our stockholders and their immediate family members. Each
year, we prepare and require our directors and executive officers to complete Director and Officer Questionnaires identifying any transactions
with us in which the officer or director or their family members have an interest. This helps us identify potential conflicts of interest.
A conflict of interest occurs when an individual&rsquo;s private interest interferes, or appears to interfere, in any way with the interests
of the company as a whole. Our code of ethics requires all directors, officers and employees who may have a potential or apparent conflict
of interest to immediately notify our general counsel, who serves as our compliance officer. In addition, the Corporate Governance Committee
is responsible for considering and reporting to the Board any questions of possible conflicts of interest of Board members. Our code
of ethics further requires pre-clearance before any employee, officer or director engages in any personal or business activity that may
raise concerns about conflict, potential conflict or apparent conflict of interest. Copies of our code of ethics and the Corporate Governance
Committee charter are posted on the corporate governance section of our website at www.microbotmedical.com.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
have been no related party transactions or any other transactions or relationships required to be disclosed pursuant to Item 404 of Regulation
S-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PRINCIPAL
ACCOUNTANT FEES AND SERVICES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Audit
and Tax Fees</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board, upon the recommendation of the Audit Committee, has selected the independent accounting firm of Brightman Almagor Zohar &amp;
Co., a Member of Deloitte Touche Tohmatsu Limited, to audit the accounts of the Company for the year ending December 31, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Audit Committee considered the tax compliance services provided by Brightman Almagor Zohar &amp; Co. and Deloitte Israel &amp; Co., concluded
that provision of such services is compatible with maintaining the independence of the independent accountants, and approved the provision
by Brightman Almagor Zohar &amp; Co. of tax compliance services with respect to the year ending December 31, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Audit Committee received the following information concerning the fees of the independent accountants for the years ended December 31,
2020 and 2019, has considered whether the provision of these services is compatible with independence of the independent accountants,
and concluded that it is:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Years Ended December 31,</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2019</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%; text-align: left">Audit Fees (1)</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">70,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">50,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Audit-Related Fees</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Tax Fees</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,500</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">All Other Fees (2)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit
    fees represents fees for the audit of our annual consolidated financial statements and reviews of the interim consolidated financial
    statements, and review of audit-related SEC filings.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    fees related to issuing comfort letter and consent(s).</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit
and tax fees include administrative overhead charges and reimbursement for out-of-pocket expenses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Pre-Approval
Policies and Procedures</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Audit Committee has adopted policies and procedures for pre-approving all services (audit and non-audit) performed by our independent
auditors. In accordance with such policies and procedures, the Audit Committee is required to pre-approve all audit and non-audit services
to be performed by the independent auditors in order to assure that the provision of such services is in accordance with the rules and
regulations of the SEC and does not impair the auditors&rsquo; independence. Under the policy, pre-approval is generally provided up
to one year and any pre-approval is detailed as to the particular service or category of services and is subject to a specific budget.
In addition, the Audit Committee may pre-approve additional services on a case-by-case basis. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REPORT
OF THE AUDIT COMMITTEE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Audit Committee oversees our accounting and financial reporting processes and the audits of our financial statements on behalf of the
Board and selects an independent public accounting firm to perform these audits. Management has the primary responsibility for establishing
and maintaining adequate internal control over financial reporting, preparing the financial statements, and establishing and maintaining
adequate controls over public reporting. Our independent registered public accounting firm for fiscal 2020, Deloitte, had responsibility
for conducting an audit of our annual financial statements in accordance with the standards of the Public Company Accounting Oversight
Board (United States) and expressing an opinion on the conformity of those audited financial statements with generally accepted accounting
principles.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Audit Committee oversaw the independent public accounting firm&rsquo;s qualifications and independence, as well as its performance. The
Audit Committee assisted the Board in overseeing the preparation of the Company&rsquo;s financial statements, the Company&rsquo;s compliance
with legal and regulatory requirements, and the performance of the Company&rsquo;s internal audit function. The Audit Committee met with
personnel of the Company and Deloitte to review the scope and the results of the annual audit, the amount of audit fees, the Company&rsquo;s
internal accounting controls, the Company&rsquo;s financial statements contained in the Company&rsquo;s Annual Report to Shareholders
and other related matters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Audit Committee has reviewed and discussed with management the financial statements for fiscal year 2019 audited by Deloitte, as well
as management&rsquo;s report on internal control over financial reporting, using the criteria set forth by the Committee of Sponsoring
Organizations of the Treadway Commission (COSO) in Internal Control &mdash; Integrated Framework. The Audit Committee has discussed with
Deloitte various matters related to the financial statements, including those matters required to be discussed by SAS 114 (The Auditor&rsquo;s
Communication with Those Charged with Governance). The Audit Committee has also discussed with Deloitte its report on internal control
over financial reporting, has received the written disclosures and the letter from Deloitte required by Public Company Accounting Oversight
Board (PCAOB) Ethics and Independence Rule 3526, <I>Communication with Audit Committees Concerning Independence</I> (Rule 3526), and
has discussed with Deloitte its independence.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
upon such review and discussions, the Audit Committee recommended to the Board of Directors, and the Board approved the recommendation,
that the audited financial statements be included in the Company&rsquo;s Annual Report on Form 10-K for the fiscal year ending December
31, 2020 for filing with the SEC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AUDIT
    COMMITTEE</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scott
    Burell</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Martin
    Madden</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yoseph
    Bornstein</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
foregoing Audit Committee Report shall not be deemed incorporated by reference into any filing under the Securities Act of 1933 or the
Securities Exchange Act of 1934, and shall not otherwise be deemed filed under these acts, except to the extent we specifically incorporate
by reference into such filings.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROPOSAL
1: NOMINEES FOR ELECTION OF CLASS III DIRECTORS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
number of directors is currently fixed at seven. Both our restated certificate of incorporation, as amended to date, and our amended
and restated by-laws provide for the classification of the Board into three classes (Class I, Class II and Class III), as nearly equal
in number as possible, with the term of office of one class expiring each year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise instructed, the enclosed proxy will be voted to elect the nominees named below as Class III directors for a term of three years
expiring at the 2024 Annual Meeting of Shareholders and until their successors are duly elected and qualified. Both Class III director
nominees have been recommended by the Corporate Governance Committee because of their past experience serving on the Company&rsquo;s
Board, the breadth of their business expertise, sound judgment, and demonstrated leadership, among other things. Proxies cannot be voted
for a greater number of persons than the number of nominees named below. It is expected that the nominees will be able to serve, but
if any are unable to serve, the proxy will be voted for a substitute nominee or nominees designated by the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Corporate Governance Committee has recommended and the Board has nominated <B>Yoseph Bornstein and Prattipati Laxminarain </B>for election
as the Company&rsquo;s Class III directors to serve as Class III Directors until the 2024 Annual Meeting of Shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
BOARD UNANIMOUSLY RECOMMENDS THAT YOU VOTE &ldquo;FOR&rdquo; THIS PROPOSAL 1 TO ELECT AS DIRECTORS THE TWO NOMINEES DESCRIBED ABOVE</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROPOSAL
2: RATIFICATION OF INDEPENDENT REGISTERED ACCOUNTING FIRM</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is asking the stockholders to ratify the selection of Deloitte, or its U.S. affiliate, as the Company&rsquo;s independent public
accountants for the fiscal year ending December 31, 2021. The affirmative vote of the holders of a majority of the shares represented
and voting at the Annual Meeting will be required to ratify the selection of Deloitte or its U.S. affiliate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event the stockholders fail to ratify the appointment, the Audit Committee of the Board of Directors will consider it as a recommendation
to select other auditors for the subsequent year, which the Audit Committee would then take under advisement. Even if the selection is
ratified, the Audit Committee of the Board at its discretion could decide to terminate the engagement of Deloitte or its U.S. affiliate
and engage another firm at any time if the Audit Committee determines that such a change would be necessary or desirable in the best
interests of the Company and its stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
representative of Deloitte is expected to attend the Annual Meeting telephonically and is not expected to make a statement, but will
be available to respond to appropriate questions and may make a statement if such representative desires to do so.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
BOARD UNANIMOUSLY RECOMMENDS THAT YOU VOTE &ldquo;FOR&rdquo; THIS PROPOSAL 2 TO RATIFY THE SELECTION OF DELOITTE OR ITS U.S. AFFILIATE
AS THE COMPANY&rsquo;S INDEPENDENT PUBLIC ACCOUNTANTS FOR THE YEAR ENDING DECEMBER 31, 2021.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OTHER
MATTERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Shareholder
Proposals</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholders
who wish to present proposals for inclusion in the Company&rsquo;s proxy materials for the 2022 Annual Meeting of Shareholders may do
so by following the procedures prescribed in Rule 14a-8 under the Exchange Act. To be eligible, the Shareholder proposals must be received
by our corporate secretary on or before April 2, 2022.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholders
who wish to make a proposal at the 2022 Annual Meeting of Shareholders, other than one that will be included in our proxy materials,
must notify us no later than June 18, 2022 (see Rule 14a-4 under the Exchange Act). If a Shareholder who wishes to present a proposal
at the 2022 Annual Meeting of Shareholders fails to notify us by June 18, 2021, the proxies that management solicits for the meeting
will confer discretionary authority to vote on the Shareholder&rsquo;s proposal if it is properly brought before the meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Shareholder
Nominations of Directors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
shareholder entitled to vote for the election of directors at a meeting may nominate persons for election as directors by giving timely
notice thereof in proper written form to the secretary accompanied by a petition signed by at least 100 record holders of capital stock
of the Company which shows the class and number of shares held by each person and which represent in the aggregate 1% or more of the
outstanding shares entitled to vote in the election of directors. The submission must be in writing and delivered to Microbot Medical
Inc., Attn: Secretary, Board of Directors, 25 Recreation Park Drive, Unit 108, Hingham, MA 02043, in accordance with the advance notice
procedures and other requirements set forth in Section 3.2 of our bylaws for nominees to be considered for nomination at the 2022 annual
meeting. These requirements are separate from, and in addition to, the requirements discussed above to have the shareholder nomination
or other proposals included in our proxy statement and form of proxy/voting instruction card pursuant to the SEC&rsquo;s rules. Submissions
must include the name, address and number of shares of common stock beneficially owned by each participant in the Nominating Shareholder
group, a representation that the Nominating Shareholder meets the requirements described in the Board policy and will continue to meet
them through the date of the annual meeting, a description of all arrangements or understandings between or among the Nominating Shareholder
group (or any participant in the Nominating Shareholder group) and the candidate or any other person or entity regarding the candidate,
all information regarding the candidate that the Company would be required to disclose in a proxy statement under SEC rules, including
whether the candidate is independent or, if not, a description of the reasons why not, the consent of the candidate to serve as a director,
and representations by the candidate regarding his or her performance of the duties of a director. Full details may be obtained from
the secretary of the Board at the address above or on our website at www.microbotmedical.com. The Corporate Governance Committee will
consider and evaluate up to two candidates recommended in accordance with this policy in connection with any annual meeting. The Corporate
Governance Committee will consider and evaluate candidates recommended by Shareholders on the same basis as candidates recommended by
other sources.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the Company&rsquo;s by-laws provide that a Shareholder entitled to vote for the election of directors at a meeting may nominate
persons for election as directors by giving timely notice thereof in proper written form to the Secretary accompanied by a petition signed
by at least 100 record holders of capital stock of the Company representing in the aggregate 1% or more of the outstanding shares entitled
to vote in the election of directors, which petition must show the class and number of shares held by each person. To be timely, such
notice and petition must be received at the principal executive offices of the Company not less than 60 days nor more than 90 days prior
to the meeting, except if less than 70 days notice of the date of the meeting is given to Shareholders, in which case the notice and
petition must be received not later than the close of business on the tenth day following the day on which notice of the date of the
meeting was mailed or public disclosure of such date was made. The requesting Shareholder is required to provide information with respect
to the nominee(s) for director similar to that described above, as more fully set forth in the Company&rsquo;s by-laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form
10-K</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s Annual Report on Form 10-K for the fiscal year ended December 31, 2020, as filed with the SEC, is available without charge
upon request by writing to Microbot Medical Inc. at 25 Recreation Park Drive, Unit 108, Hingham, MA 02043, Attention: Investor Relations.
A copy of this report is also available through our website at www.microbotmedical.com or, alternatively, at <U>www.sec.gov</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Householding&rdquo;
of Proxy Materials</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Some
banks, brokers and other nominee record holders may be participating in the practice of &ldquo;householding&rdquo; proxy statements and
annual reports. This means that only one copy of our proxy statement and annual report, or the notice of Internet availability of the
proxy statement, to shareholders may have been sent to multiple shareholders in your household. The Company will promptly deliver a separate
copy of either document to you if you contact the Secretary at the following address or telephone number: Microbot Medical Inc., 25 Recreation
Park Drive, Unit 108, Hingham, MA 02043; telephone: (781) 875-3605. In addition, copies of both documents may be obtained from our website
(www.microbotmedical.com, click on the button &ldquo;Investors&rdquo; and then &ldquo;Presentation + Resources&rdquo;). If you want to
receive separate copies of the proxy statement, annual report or notice of Internet availability to shareholders in the future, or if
you are receiving multiple copies and would like to receive only one copy per household, you should contact your bank, broker or other
nominee record holder, or you may contact the Company at the above address or telephone number.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Other
Business</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board knows of no business that will come before the meeting for action except as described in the accompanying Notice of Meeting. However,
as to any such business, the persons designated as proxies will have authority to act in their discretion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
    order of the Board of Directors</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Harel
    Gadot</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman,
    President, and Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><IMG SRC="proxy_001.jpg" ALT="" STYLE="height: 852px; width: 670px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;<IMG SRC="proxy_002.jpg" ALT="" STYLE="height: 868px; width: 670px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 22; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>proxy_001.jpg
<TEXT>
begin 644 proxy_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2D Z8# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@-&DMTC;4+BT=8GW#J93'WR?XL<FFP>#8+>:-TG7;'=&X53$3_R[B #)8DX
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M"CGKP<.W3M^G]?H-^\KK^KF?K^@W*^&=+T:Q:>:ZL;F.=94@94#*'9,=0%#
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MT2J\T(^1)3&'Y<%LD=%!;.>,8):OL#[G;T445(PHHHH **** "BBB@ HHHH
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M97MIE?=)+%A?F9QA225.%&<CBK4'@*:U4&S:TM9I4'VB:+.YY!(S!SQ\Q ;
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M &>.7;BJ:MLP39VMMHFG6^F)8Q0/]F$HG"O*[,7W^9N+,=Q.[GD_6LJ^\/\
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MH$Y+L2?E51SZ4^[\/Z9>B?SH) \\RSO)%/)&XD"A RNK!E.T8^4CC/J:TZ*
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M>0S#//'1+O7/&8NXEAM]2646;K<QFT#1+-]G+H\9$/.9 !S(V#QMY!JFG?\
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MJ>*VZ&K.PD[A1112&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 5F>(M1BTGPYJ-_-=_9$@MW;SP5!0XXQN!&<XP"#D]JTZ
MJ:K<R6>D7ES$\:20P/(K2*64$*3D@$9'MD?6IE\+*A\2.;\$:EJ$V@1W^MZJ
ML\5T8Q;R3O;[F8@ @&'Y""^=H!+>O/ CNM<O9O%#V5KJ7EW-O>11#3!$I\V
MA2\SD@L  6VLI RH!R3BN<;Q]XIMK2(ZC'964QF42[]+DEV1F REML4[?*"
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M=7VE6-S<6^/)EGMT=X\'(VDC(YYXK0HH CC@AB>1XXD1I6WR%5 +M@#)]3@
M?A4E%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !2,,J0#@D=:6D;.T[2 <<9%)[ ><:3\/M
M6L;:XBDU!1*\R/\ :%E3]Y@-^]*K"A$GS#EG<G'WN*98_#[4[33Q#-'87H$I
M8VES.! Y*X$P\JW3;(#SR&)/\8/-1:+XD\01LMW)?VFH(J6D5Q$(G!+O-+&0
M@#D(P( ;(.2N,"MKPCXMU#Q%IFJ3WEM!&;=-R^5)'E&(),;JDTC!EP.3L)S]
MU<4VK)R\OZ_K_@!O*WF48OAR1=:I,UMI<4\T4XM;J-6,@>0Y+M\N5.,KD,QQ
MWYQ4?_"N9YUG>:STFV_<S?8[2!F:&RE;RMK1DH,<QLV0H(+< \FK,'BG71!)
M-G2A 8IE@68.A5XXU8-)*SD;3D@\#IG=6;:^-=<OYK>2UU'30]Q%#$D4MIE&
MD-P(WD3R[A@ZA6'W7(R1R.E5&Z=D3HU=FP?"&IQZK]K6/2YWW.T4]P\F^TS+
M(^$4 ;@X<!AN4<<[QQ679_#W6(H]0W?V7;+=1R;;>V;$<;M'L. L*#!.#G&?
M4G%6Y/'MVB?9_/TT74/G)>2M&P2U*W"QB21=^578V\@D=CN YJ ^+=42[N+C
M[39Z@JQ1RV]M:K(GF?NY\NOS996,8Z@CD8+8!*6EF.W-[O\ 7]?UZZWA?0I8
M]9UNXN!*;!9'M;"*:$QE8V;?*1GDJ78@'H0@QQR<VU\#:U:V4OF2:7>W!C:V
M5+G+1O;J(U16RAY*HQ/! 9NC5&WC?7)89?L-UHEXD%M/=->PV\AAF$:QL40"
M3@@N5)W-CTZK6YHWBBZOO&-_H]R]F4CC\R%+;:[(OR_ZQA*65CN^ZT:^Q;%%
MOR_(K;4H1>"M33X>2>'OM<"S_:&E4(5\MHS)O\H_NM@7'R_ZLK_LXXJPO@R]
M;PQ:Z7+J4S(AB\RSD>)X"!,)#AE@1N%!50 JX &.]<]?>/KVXU62U@U33XK6
M*XC=+QH3&D0WE7291,2<9!(;R_I@Y&K:^-=5N;ZUM\Z<LLIC1+8QOYMT&)!N
M(_FXB&,XP>.K#C*4KZ]_Z_K^F)NS]/Z_K^D(? =S9V\RZ?9Z,WFI-%+!,N(Y
M8S.'C4YC8?+'E1E6"G@ BI?#/@G4]&N-->YN;61+1FSL8YV_Z1M  15&!,@P
M  ,'   K(G^)>M?9X)HM/M8XVD\AY)=B)YZ*GF1;I9HU&78J#DD;#\K=NA\3
MZ_J6DZG83036\4$EA/(UO,A8-(&BP=RMSM#,QQGY5;ZBDVOZ_K^F#5]'Z_U_
M70I:KX$O-3U&^=H].\JYD=GN6=_.N(V 'DR#;C8O;YCT' Y-:'BGP:FK6]G#
MI]EIR);6L]K&)!Y?D+(@4&/:IQC&,#'!//&"L/B>];PE>ZNKV5V+*;FYMT80
MW$"E2\D8W$_=+@?,PRO>LNT\;ZK>75LF=/B-T4,%H8G\^:*0DK,OS_=1=I;Y
M3D@\KP*GX=%T_P OZ_JXM/B[_P!?U_PQ!JOPXO)[M?L$MO;V*73R1VT3I$(0
MRQ_O$+02!9 RN?E"GYL[ADUT/B;PQ/KMQ!AH&@6$12K,3\X\^&0]!W6-A]2/
MPYOPGXYUF_U32M*NQ:W >WC\V4&*-Y28PS2*&FWG:V4(6-AE3\P^Z-J^\87$
M&KW6EPMI_P!LBN)$6*=RG[H6QE5V.>%+@C=C& >XJG=:!:S,2_\ AK=.)%LH
MM,B3#H@&U<1>>\BPX:%UV%7&05(!0?*>HMCX<).L+7\%G=2I'9Q![AA*ZI'*
MSR(&$:#:0P4 *H(&" *KV/C35M4BTHVDMB;RYDDMWF:(F $-'RJQSNC@!NH<
M\@CY>15EO'&IK/IL<DFF0R3&W1H7C??<F2;RW:+Y^ H&<$-]X9/J).]OZ_K^
MNX2=]611?#V_AUW3KD7$(L[5B$CBD1#;H)78*FZ!SM*LJLJM&,#'(Q75^%=*
MFT+18=+>ULH(K<$(;5R0^68DE=B[21@]^2?3)YG7-4UV/QZMA9:K:1+\DD5O
M-$S87R9B68+(N]=RCTYQSQR_2O'.IZCXHL=.>QMXH+B"*0JTD:NP>(.9$W2A
MV4$[<"-NA^;M25VEY_U^@/=^7]?J:&I^%[N[TLP>387H&I27C6=V[""X1BV%
M<[6Z;@WW6&5'UJ#6_"%YJ'A#3-+7[/<W=FRL'GE C4@$9VO%*' S@!E]\@U4
MU+Q%K6GZCJ\=A+;,L+W-R?M:/)A(H8&V)AUVY+MZXSG!Z'.O_'>MZ5JUQ:J;
M*Y#WK!%D\N+8NV,I#NDG0!F#$AAN/!.P]A+9+R_0IM[OS_4;XFT'45O4ADTV
M/4IKO/E2K!(4MG++EU*J0C$9SN*C:/O'E3U?AOPH-!O&N$CM8VFMREPT(.Z6
M3S&8,QP,X!QD].G2L6X\5>)TM'N4?2579?W"HUK(2L=NX4(2)>6;NW 'H<<T
M;SQUKEU-JUM$+33EM6!\R;RRT"+*HWNOG[RK*2<E$ '<]:273O\ U^O]:"Y>
MO]?UH)=^#]:0Z7%<:=IFH10F&U6!I9&CDCC2X^:4^6=@(=1C##/'-=+=>$&O
M-$T2RF:W>?3B6$[IN,9\IU!CR,Y5F0CD?=!SD57\6>,)]!U33[6UFM9'E:(R
MV\D/S/&[["Z.95X'.<*Y&1G .:H6_C/6ET]9KZ;28//@MKA;HP.(;5)2X)D!
MD^8#8.=RCYO;)>Z_K^OZ^1;;;YOZ_K^M2;2/ 30ZG97-_8:3';6SAUL[<M)&
M)0I F&Y!\[$Y/'&!R3S4>O>!=3U3Q)J.HQ7B&.YMWCB+2HC19BV>6?W#.8R?
MF($BC)^Z2,GHO#6H27WAJ%Q=13WWE-(<L6ZLVTD$YVG'&>PKA9/'VN:S!;V]
MO!%9O.\,Z2;)%*H)HXG4G=_SUW CNOUS0KMI?UJ1'35?U8U(/ &JQ:CJT[7R
M-]K1PDAE4>8&8,(Y%$(<J -H)E; )PHZ41?#OSM0$MWI&A1VDGD>9:Q%G6-8
MY';RUW( RG<IZ*/E VTT^/-;AUFQTV6TLG9IGADE&R%;@K,\9$?F3J5("AL
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MZNGNOW%K(D4SK&[8=]I4# YSO7IGK6)_:'A36-2_M0)?37=K&LA5+:Z&X(Q
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M@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MVC:BDJ&,L8#<Y_B)&<*<563QGK2QS74D>GM;2)=&!4A?=%Y,J)N=MYW##EB
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MW%4GKK_6M_Z\M :TLOZZ?UYE'P7J5WJWAJ.[OIO-G-Q<(7VA?E69U48  X
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MH4[1LZ@E1G%+ETY0V?-ZF+9?#:_@L$WW-HFJ+B,7Z%C(L8M3#@':#]_#8X&
M.X%;6F>%;RU\.ZU8+#I^FR7W^IBL79HHOW:IUVJ>2I)P!U]:QM0O?'%J;9[>
MXN95N+JXSYMMA8MLI6*,B*VD;RRG)8[2>N\=*DM-0\0Z5%<VS#5IY)9[CRF:
MQ,@1_M&1\PCQM,;9!/'4 Y&!5VU_7D)O^OO(=2\ ZK>Z%-IT%EH-HDTSRK''
M\PM"8T53$S0GH5;.%4X8$,"*;)\.-1_M**>)K.*,733-]GE1'RS!C*"]NY$G
M5?E*D@#YN<"Z@\7J%N6U;4W(C\\VYLH=I;SMHBXBW;=G/7=WS6IXKBU!]4L'
MM6O(H8Y(6EEM+<.Q'G+E2=C';@Y('IGM23U3$]FB+Q%H=QJOB[3UMGEBMWBW
M7["$E'$3;H1OZ;@Y)QUQFLRP\$ZUILD%S:PZ1#)"55K>.>01SGRY$>=FV9$C
M>8"1@YVX+'.1:UR76;+Q'?2076L164WV;?):60N/)C"R;C$/+;+;P@(PQ 8G
M'0B_>G4?^$;TK6[FRFFU2P99GABB_>NI!1P%&?F*MG:.X I+X?ZZW*>_]=+$
M&D^$CHVF:K/-;VLNH3V20+-"I:0JENB%,D X+J2![CO69I7@&2>VT]KZQTVW
MACD29K2/<ZAQ Z"4AE'[PLZDYZ;1R2,T^W7Q#I-S8V4)O4:013-'%:"2&:26
M0M<F64J=A4'*_,N>.&Z55\/7GB^WU72["9KQ[)0$D>\MW4R<GS-Q6V(!!X4F
M1 1@_-G-4[N6O7_@_P";)=N7T_X'^1)%X U5;%H(AI=B_P"Z!:VDD/F,@?=*
MWRJ0\NX*_4A<_,QQC6T+1)XO&FHW15XM.ME_T: Q%46>15\TH2!N4;%P0,9=
MJ@U7PC+KGC.\NV2QAC2*V"74VG>9< @L3Y,V\>6>G9NM59+OQ;:QP.U[JLTT
MRO)#$NGQLC2^80(9"L>8XPN#N)!.3\W04E*^_7_AA/\ +]!T_@K5'L;JU6QT
M*43R#SY9B7>[&6/FN'C=%D7(QE7SC&0, 1:?\.[FSTAQ<P:7?Z@6MU?SR=EQ
M#'&JF)VV$A2REL;2,@<4V_U?Q>EA*UK_ &BT_G 72M8;!:CYN(&6&0R#A.1'
M+U/([27&I^+4O84,]QF;3\M]GL)6BMY=C'S&W6^7.0/E#JPR/W9J5L7_ %^)
MJWOAB_F\$VFB)!I<SHV)H[@!H]OS'*%XW&X$J1N0],<9S6)9?#:_@L$WW-HF
MJ+B,7Z%C(L8M3#@':#]_#8X& .X%6+*Z\3:A;:=DZA:3R'R9KQK1&DV>9RPW
MP)M&.S1KCK@]3%%XBUR'4["WOK^\2830120BR39*A)WO(VSY'..%!7CD+CD-
M:.PE.RTZ&G9^$+I/"NO:6UIIED=24K';VCL88P8E0\[%/)!/"]ZSY/AQ+_;M
M]+";:/3I[=X88T\M!&K1;!$4\@L8P?FQYH&>=N>O0^(=2NFTO3[K3)[V.SN&
M#RW-E9^?,J%"4Q&58X+;0?E) /;J.>OKOQ)"YO8$U&":Y5RBPZ>)#)-&$6..
M4$/Y<;'S&SD#G[X[O5NS]/T!/9H3_A!=5FT\:9+;:1#8#>1'%,Y'SJ@9-OE@
M;1M;![@C@5KV'@J#3?$:ZI:6MC;[;MF!A3:PM_LXC$8P. ' .WIQGK6/\0=-
MDO\ 5K-VLHY&^P2HDCZ+-?\ EREEQL:,CRF]'/I4]U<>)H6FGFO=7M;0W2P^
M7:6,=P\$8@5LH/+9GS(2I8[@!Z=0)]2;+8VK3PW+;>,7UIH;-PZ3)YG/FH&*
M%<?+ST;/(QGOFJ%GX(>#5H]2E2S:[BN8WCG&2Z1C?N4''&=PX'7OT%8UQKWC
M87ML(++41-]F*W<#VH,*R>07#1D1X/SC',IP>"O(-20)K\XNQ;W6K?9I?M,[
M/<:<B/=%885C5T>+ !.\8"J3@T<MOE_F5:[MW-74O T>I>);B]GL=-EM)YEF
ME,@R\A$#Q;67;@@$J1DGJ>!CFKH/@?5-,\46VJ7=ZLRQP(C2)*@;(B"&,@P;
MV3(+?ZT#.#MS6=?:EK]O?O=S/J$+0"6)LV $5M&TT2H86V8D=H\L%R_S#&!]
MTI9:_P"+[K4[,6TLT^G_ &EXUGGM60R[9F4K*L=N^TA O4Q<DY)Y <;JR027
MVF6Y?!^HZGJ>KW$=M9VF^YFVW+,XEND( \IQM_U1QG()^G7*S> ]0<Z?+#:Z
M7;R6]TTR0+*'M[1&V?)'&\!#?=)ROE$$G! K>\51VFO^%GC+W;637*K,UK9"
MX?$<GS#RF5MPW+@_(WT(JM::9.DOA67[/-&+626/RXT\N..+RY C-&H"J2-G
M88)P,9Q4Q73T_K^O^'F5M_7^OZ_X;!E^'VK!-)AM8-&LTTUT>.>V $V!(2X!
M,.?F4@X5UYR#N!S6-8^#=4UZVG,&G1Z<D:VZ26\T9B6[=!+O9_.@<;LNK$B-
MP6Z,?O5T7B/3=6/B[4)K"VNFBU2VATV:2-3MC0[V,N?]D;A]76LNRO/&NG6=
MO8VUM-!!;Z2BP1FWD;)%N.<"!AY@DXVM*O3&P]2T]/Z_KHOO\B[7?]?UN_ZN
M;VO>&M0:RT:VWR:TB7$:O9ZB4, "P2*2[I#N.3C)8$9(X&<54'@36/[7TVY+
MZ8%LH_+^T(-LTB&(H8V)C+%0QR/WF".JY&:EN+OQ98RW4$%SJ5[=Q0G[,DMA
M'Y,X\K=O>5$4(XDRH4'H!\ASNK,GO_%E[X>:"].H&.:*=8S;V+R23-A0L<P:
MWC*#E\,J*.!\V>KM=_UUT_S%S62_KS.@T3PE>Z;XAAOIHM/81AMUVCMY\H*
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MI&<''0\]JFH;N[C6@4444@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M[&UM$D<R.MO"L8=CU8X R?>K=%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MS_OS9?\ R/6AJ>G75_Y7V;6;[3=F=WV1(&\S.,9\V-^F.V.ISGC&A10!S_\
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MY!I\TR6\$DS[BD:EFV(6. ,\  DGV S0]-P6NQ3_ +.NO['^Q?VS??:/^?\
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M0=-X)$FX_>_)M6=@6JN=I_PCVJ?]#GKG_?FR_P#D>C_A'M4_Z'/7/^_-E_\
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M>.Q*,Z$R32Z9):S L5.))"=DY./O+]W;CO3MK;U)-#_A'M4_Z'/7/^_-E_\
M(]'_  CVJ?\ 0YZY_P!^;+_Y'K"O]-%YX[OOL6BVT5YY,4@U>2UD21'7.0DG
MD['R"JG]X.,C!P16?JMAI[:2PM_#%Q(Z^7]MAN;"5EN)A)&1OQ&YE. V95#@
M#/)SBDN@^IWNIZ==7_E?9M9OM-V9W?9$@;S,XQGS8WZ8[8ZG.>,9_P#PCVJ?
M]#GKG_?FR_\ D>N9O])T==*@BU?PP'DM[Q EM#I<EW#;QLRLPBVQGY,*<G"^
MA R!5Z;3-!MO%=I'9:"8[V&R:&"[_LF1EC?""/\ ?[-HPH(R6XZ<=*/Z_"X'
M4:9IUU8>;]IUF^U+?C;]K2!?+QG./*C3KGOGH,8YSG_\(]JG_0YZY_WYLO\
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MNP+O"^I!S[\5V=%@ZA1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MHH I?V38_P#/NOYFC^R;'_GW7\S5VB@"E_9-C_S[K^9H_LFQ_P"?=?S-7:*
M*7]DV/\ S[K^9H_LFQ_Y]U_,U=HH I?V38_\^Z_F:/[)L?\ GW7\S5VB@"E_
M9-C_ ,^Z_F:/[)L?^?=?S-7:* *7]DV/_/NOYFC^R;'_ )]U_,U=HH I?V38
M_P#/NOYFC^R;'_GW7\S5VB@"E_9-C_S[K^9H_LFQ_P"?=?S-7:* *7]DV/\
MS[K^9H_LFQ_Y]U_,U=HH I?V38_\^Z_F:/[)L?\ GW7\S5VB@"E_9-C_ ,^Z
M_F:/[)L?^?=?S-7:* *7]DV/_/NOYFC^R;'_ )]U_,U=HH I?V38_P#/NOYF
MC^R;'_GW7\S5VB@"E_9-C_S[K^9H_LFQ_P"?=?S-7:* *7]DV/\ S[K^9H_L
MFQ_Y]U_,U=HH I?V38_\^Z_F:/[)L?\ GW7\S5VB@"E_9-C_ ,^Z_F:/[)L?
M^?=?S-7:* *7]DV/_/NOYFC^R;'_ )]U_,U=HH I?V38_P#/NOYFC^R;'_GW
M7\S5VB@"E_9-C_S[K^9H_LFQ_P"?=?S-7:* ,^71;*2,JL?EGLRDU#H<DFVX
MMY&+>2V 3^/^%:U8^C?\?FH?]=!_-J -BBBB@ HHHH **** "L?5?^0GIW_7
M0?\ H0K8K'U7_D)Z=_UT'_H0H V**** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %<U\0O^2<>)/^P;/_ .@&NEKFOB%_
MR3CQ)_V#9_\ T T 8GP2_P"20Z%_V\?^E$E>@5Y_\$O^20Z%_P!O'_I1)7H%
M !6/HW_'YJ'_ %T'\VK8K'T;_C\U#_KH/YM0!L4444 %%%% !1110 5CZK_R
M$]._ZZ#_ -"%;%8^J_\ (3T[_KH/_0A0!L4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %<U\0O^2<>)/^P;/_ .@&NEKFOB%_R3CQ)_V#9_\ T T 8GP2
M_P"20Z%_V\?^E$E>@5Y_\$O^20Z%_P!O'_I1)7H% !6/HW_'YJ'_ %T'\VK8
MK'T;_C\U#_KH/YM0!L4444 %%%% !1110 5CZK_R$]._ZZ#_ -"%;%8^J_\
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M%% !1110 4444 %%%% !1110 5CZ-_Q^:A_UT'\VK8K'T;_C\U#_ *Z#^;4
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M5&3A00!G@4?V!91O!+;^?#+;Q[(MMS*$/''F(' D_P"!9/O0_P"ON_S S?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MFGU%:VT=G:0VT(810H$0.Y<X P,LQ)/U)S4M-VOH);:A1112&%%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M10 4444 %%%% !6/JO\ R$]._P"N@_\ 0A6Q6/JO_(3T[_KH/_0A0!L4444
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M#!64@J&4GACW'.*Y74/AYJ.IWL[W6OP-!<2!YL:>5F?_ $<P'YQ(%&58G[F
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M<RE?-.3RP!SQQP<<[M%%Q;A1112 **** "BBB@ HHHH **** "BBB@ HHHH
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M-BL19R'\S!Y  R.1D\>].T.3PO;-))I.JV\VX1Q,?[2:<#.611N=L?>. .W
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MW[MNU7=VQ\W&W(P>,"A?U]X?U^ R]GUR'7XUBNM-33-AE>.2VD,NQ2@;YPX
M/S' V'I[\30Z^)"%?3;V&0R*HCD,62K;MLG#D;25(_O ]0.M55OO"^HZU!>1
M:U:SW@C\F..+4R497YQY0?8Q/!R5)/'H*35;'0=$T"^N-0EGALE(EEEDOI0X
M(.559"^5&> H('.,<T;(+:D\7B(7(M?(TR_<3HC.P6-A;%S@"0!\GU.W<  2
M3TJBOC."RT&2_P!7@DMGA6/<7,4*3EL@-&7DPJDAL;V4\<]B8])'AJ>WT>>&
M=[&6=&6SMSJQW3*">/W<S+*!DXY;:#QBK-GIWAJ=Y=/L[XSS)"('C35)7DC6
M-C_TT+*RL2-PPW;--@GU-C2M3M=9TR#4+.19+>9<JRLK#K@C*D@X((R"1Z$U
MD6]]KUK>7LFHR6%U:1-Y<=O9VS1S%VVE%W/*5;[Q!)"C.#P.EUM5T71+BRT:
MXU2&&YF7%M%=W1:67! ^\Y+,<D#DDG\*H6O_  C]S)K!:YDBG9BU]#-J3%H0
MA($@42$0CY<@KMX Z$<)[W6W]?UY MK,D/B.5;ZW5M/N?(F3$B!$WVKAMI\Q
MA)@CYE&$W'J>1T;%XPMW-UYVFW]LMO'([/<>4BG8<$!O,QS@\G XY(XS+;Z%
MH>HV44]K//<6SPA$F@U*9A(N\/NW*_S$L.6R2>A)%5'TKPH"T#WV'+NA!U:7
M>'7+L ?,R&7<6]1@'C:,# EMO%RZ@NERZ=I5W>V]^)"98)K<B'8P4[CYF& )
M/*%NG&:GD\4VB:GJ%@L$LDUA$)90DL.2,9X0N'Z=RH![$U5:U\)/I-I*]_ U
MA).6@F;4W*3._!7?O^<,>J$D$]B:LO!X>GUJX@DODEU"5&A>U?4'8J"N6"Q%
M\(=ISE0#CVI]?Z\A=#4LKT7HGQ#+"T,S0LLFW)([C:3P001WYY /%5+>YOEU
M/4%NI[:2W1E%K#%"4D)*[B"S2$,?H%Z4D$.C^%[4AKL6L5Q,/GO+UFWR$  !
MI&)).!QGD\]2:HM8>&Y_$4__ !,Y#JI#-);+K$P*?)M+"(287"L.0HQD$8ZT
MO0?J.G\4FSM+*272=1FDN49BL"19C8,%VL#)C.YE'!([YQS6A%JCS73JEI.8
MOLJW$9P@\W/93OR".!A@!SU/..=M;?PH+=I(;JYEMK>98HII-:DD21W93A6:
M8@G>@&#@Y!P.>=*WLO#MIX@ABBU)QJ<,7E):-JTK$(%'6$R$'@@Y*]P>O-'3
M^NP?U^)6E\=VECX?M-5U:QFT[[4P$4%S<VREP5#%@QE"XP>A(8X^[5U_$7VB
M\LX]/@DEMI9(Q)=>6&BPZ[@H.X,&P5;.TKVZD5!8:9X7O[::RTR\6;8^]S9Z
MG(98^2H&]'WHHPRA00!@C'&*COX--7Q+")]*U-FB$4GVU+K$",6VH642AF;*
MXW;#P<$X)I]0?4ZFLZYU=;:_2V-I</&2JR7*[/+B9B H;+!B22/NJ>O.*@TS
M4--M=)G=M<MKN.T=_M=T]RI6-\DL&)8[,9QM)X&!4<\WAVYU&RNY-2MC<2@M
M;*M^52<+R3L#;9-N,Y(.WVI 6M)U<ZJ)F&G7EJD3M'ON/+ =E9E8#:Y/!7KT
MY&"><337DD>J6UJ()/+E1V,V%*Y'\/WMP/4_=(XZBL+3]1\,Z+932Z7J7VN!
MYD:8C4S<B+S'*[R9)#M7<3G'OP<5:N3X>U'4-+U"35@9I3_H/DZH\<<^.?E1
M'"R>_!R.#Q3ML'<8GBO9H^H:G?Z1>64%G(R9EE@Q+M<IE2),+R.2^T#/7 S6
MU8WB7]C#=Q#$<RAU^=7X/3E25/X$UC6]GX<N[N_M[.]5[J8L;A+;47$B8;YM
MNU\QC=U"XYZ\U<EN+;P]9VUO%:73VXX+)\_EC(R[N[9/+9/)8\G!YI=/N![E
M?2KO5YK^-+RYL9(&CF)6&U>-LK)M7DR,,8ZC'7TZ4_7M2O=/DM/LS1Q1.Q\R
M66UDF0=,*2A'E@\G>V5&,=ZDL;*RCO\ 41#;W,,KG]X6G8J0W.8QN.P$Y)P%
MR>>O-27.@V%X;8SK<,;9=B$74HW+QP^&_> X&0^<]Z%T!]32HJ)($2>28&3?
M( &!D8J,=,*3A>O. ,]ZEH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %8^C?\ 'YJ'_70?S:MBL?1O^/S4/^N@
M_FU &Q1110 4444 %%%% !6/JO\ R$]._P"N@_\ 0A6Q6/JO_(3T[_KH/_0A
M0!L4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0GIW_70?^A"MBL?5?^0GIW_70?\ H0H V**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *Q]&_X_-0_ZZ#^;5L5CZ-_Q^:A_UT'\VH V****
M "BBB@ HHHH *Q]5_P"0GIW_ %T'_H0K8K'U7_D)Z=_UT'_H0H V**** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6/HW_'YJ'_70?S:
MMBL?1O\ C\U#_KH/YM0!L4444 %%%% !1110!Q^H:EX3MK;4+>$Z4]PQDWB8
ME8S*<Y#R ';SU]/2M.[017&D1A54+M4*C;@,%> >XK*N],DTZPN--L_$,GDA
M'$>GHMOYY!R?+1GQZX!;\36G<0I;R:-!'&T21A$6-CDJ!M !/?%"V![F_111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M2Y&9B[;LR$3#<P/(.!SSBNIU+>+_ $SS"I?<-Q48!.1G K:K'U7_ )">G?\
M70?^A"A:*P=;FQ1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M"@9'' I!K?A77--COCJ&DWME#.FR9Y8W2.;^'D_=?D8Z'FF]=OZU_I"6F_\
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M"S[P@$B[/DR2>F[ 'KQ2?VUJCSV5O%I=J\LOF+/F]8+$R%0VT^7EQ@G!P#D
M8')#H!X3N]4O;>W&BS:C=*5O(X_*:655.TB0#E@#D'/3I3=1M/".F&QDU.WT
M2T-H/]":Y2*/R0I'^K+?=P2.G3BA=/Z_K^OF/J06_B>]=G\_3;9%,LD$!CO=
MY:1)/+.X;!M7.#D9([CIF9];U7?:01Z5:/<R2O#.OVU@D;JH;Y6\K++C/. <
M\8ZD1V.F^']&O)K>>\M)[[5&DD_TH0":9"2Q0;54N@))YSC/6DMX_ ^I"TBM
MD\/70L5:2V6,0O\ 9U!!+(!]T E22,=J:_K]?Z_('Y#+GQ5<#4-4L;6QC>2V
MM9)H)7:58Y&3 968Q;>"0/D9SP<@5<@U/49K6Q>:"R25K@1W2VUX9!%D94#,
M0W$Y7(.W /!/>;3K;P]J#MJ^F0Z9<O.Q+7MLD;F0XVGYUZG''7VK+2W\&WTO
M]BW6DZ/'+8R2>38W,,&5  8R1ISA2"#G ]\4EIN#UV+M[KMY:R7#1V$$EN@=
M(F:Y*N\JH6*LH0A5PI^;)/\ LU>TF]NKV"7[9:1VUQ%)L:..;S5P5# [MJ]F
M&>.#GKUJJD/AK5;MI$CTF\N;NT^9@L<CS6Q..3R6C)X]*GB;1-)OELHFT^RN
M[SYE@0I')/M &0O!;  'L *?DP(Y-5NEU0P):0FU#^1YIG(D\W;N V!"-N#]
M[=G_ &<<T_0[^^U/3UNKVR@M/, ,:17!FR,<Y)1<<YQUXP>.@@EG\,R7;W\L
MNDO=+:N6N&:,N(%.'RW78#P>V>M4-,UOPAIFD17&AMI<6DRSE99K!H8X('V;
MMTF"-IP .F>1D8I('Y%J;7[N#6+BWEL;864$J1O<?;/WGS@%3Y>SIDG/S=!D
M9Y JVOBRZN])O+J+2QY]M<)%Y+R2Q!U8@!@9(E).#G[NT]F/6I1:^'X/$":M
M=:E:376H@"R6X,' V@$0-M#D,,9&YJ5-/\%2F71TL_#[EF*R62Q0G)3YB"F.
MJ[\].-V>]'34!_\ :^LQZU#:W-EI<-L8$>5S?ON61F90J@Q /DA0,E3S^%5'
M\6WUMH\MW=Z.JW!$300V\TEP'\PD#=LB+CE3T1N,'U NK/X7.EVVL/\ V1'8
M68:*VO':'RH4SLPC@[54X P".P([5'&G@Q+.W2-=!6UU&,6\"J(0ER@)(1>S
M@$G@9')H\@'6^OZC>3::EOI"JMW"TLAN97@:+8ZJPV-'N/#9&0">X7K5>37]
M0NH]0BBM3:W%I<1B)&+JTZ^8!SYD04*W(RA?&>H-230^%;77--LETS2GU* !
M+=(XH/-M(\$A@I(94R,#:.I^IJS>Z=X7TJRN)[^RT>SM)9$>>2>**-'<'Y2Q
M( )!Q@FG_7XAKM_74=!J5]/)IIEM8H5EDEBN EQNVR(&X&8_F4[2<Y4\#@Y(
MJ+1=>O-2N1%=V%O;JZR&)H;OSB3&^Q]PV+CDC'7WP>*R]9E\&:=JFE6LVD:3
M<W]S+YEHBI:JZ%FR95\QEZMS\N6)Z XJOI+^'8-1UGP_;77G71BD;4-2$MHD
MJ ]5?9M?Y=W4H0,X+9XI?\'^OD%CNJY[3]:O=3GEMIK6*S21IX89[>[$L@>-
MBI)5D '8C.[T(];\&I:5:Z##??:K6VTQ(EV3-,@B5.BG>#MQTQS6/I]CX6L3
M(DM_I][+K3R;6NOLY>Z5B2T8VJOF*"6X.[J>:+:M GH-O?%-QHVG:0AL[K4K
MFYA\R5HX)78JH7<V(8F&XEA@$(ON*N0>)C/K]WIJV3LL4+2Q2HLG[PJ0&7+1
MA,Y8#"NQZY IL-CX-?9HD%KH+>5,SI8I'"=DJX+$1CHPR,G&1D5I_P!AZ1]I
MEN?[*L?M$V?-E^SIN?(VG<<9/''/;B@/Z_$YN3QS/%IUO-_9$LEW+*RM;117
M;M&JA2<C[/O#888!0*?[U=>LN^W$H1QE=P0C#=,XQV-4#X<T,Z>-/.C:<;(/
MY@MOLJ>6'SG=MQC/O6B8T:(Q,BF,KM*$<$>F/2A[!U.<M/$%_J&EBX%BEO*M
MW'%-"TLB/'&6 SB2$$GD<8P03A^AJ>?7;U=9%G;V%M) 9C;^;)=E'WB,R'Y-
MAXQCG.>>F.38D\+>'I;+[%)H.EO:>:9O(:SC*>8>K[<8W>_6HW\+Z>^N1:H4
M :*#R%@6&()MP1R0F\C#$;2VWVSS1_7X?YA_7XDFAZI=ZG 7O;&.TD*)*J1S
M^:"CC(R=JX/!R,'ZFIY;BZ76H;<1I]F>W=PWF\EP5X*[.F#U#=S\O0U)9Z5I
MVG$FQL+6U)18R8(53*KPJ\#H,G [5'<:'I%WJ,>HW.E6,U]$ ([F6W1I$ SP
M&(R.I_.A[Z BOH>JWNI(_P!NL(K1_+25!%<&8,C9ZDHN#E3QSQCGJ!5U276Y
M/%.FVED\46GB-I[AQ.%D?:R@KM:%P1\PZ,I.>HQSJV6D:;IK;K'3K2U;RQ%F
M"%4.P$D+P.@)/'N:2;1M+N=2AU*?3;.6_A&(KIX%:6,<\*Y&1U/0]Z?5!T9D
M2ZO>WUE?0J5L)HK,3K-;3+*RL&<%</'C'R=2#D$\ BM.4SKJE@ZW4@BD1U>#
M:FQCC(;.W=D8QP<<]*CE\,:!.)Q-H>F2"X),V^TC/F$D,2V1SR >>X!H'AC0
M!):2#0],\RS %LWV2/, !R AQ\N#SQWI('_7X%K4KQK&R:9(UDD++'&C/L4N
MS!5RV#@9(R<'Z&LV;6=3MX%:;2[=)8U:6Z3[82%B4D;HR(_G)QP"%]R*V9X(
M;J"2"XB2:&12KQR*&5@>H(/!%4QH.CB"U@&E6(AM&WVT?V=-L+>J#'RGW%"
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MJC X_B5B#R".E=)11U3[!W,&UT*]M]6^TOJ,3VBF?9 +;# 2L'.7WG)##@X
MQQC/-1PZ#J:6]C#-JMM,EI.CHIL2!Y:*5"_ZS._D$L21D<**Z*B@'J<W#X<O
MXK-+=M2M2)(O(NRMFPWIER/+_>?NS\YY.[IT%6K'2]3M=9U&\DOK&2WNSN6-
M+)ED0A0JYD\TA@ .FT9)[=*VJ* .<71M?.D75K)K.G&YDF\V*9--=5CRVY@5
M,Y)ST!#*1]:I:CX*N-22R:74U6:*/R;@1+<0Q2Q[B=H2*=,=<?,7^E=A11Y@
M8$N@7C:K'<17]LEK'<BZ$+V>Z0OC:W[S>."I./ER#W(XK0U.SNKE8I+&YAM[
MJ%B8WGA,L?(P<J&4GC_:']*OT4 88TC5(+^QDM-2LTM;>,I+%+9L[R;F#,5<
M2@+T&!M./>GV]AK<%YJ,K:EI[17!+P(+!PT38"J6;SOG "C( 7)[CI6S10!S
M\.C:PNEQPS:K9/?03F:"9+%UB&01AXS*2WWFZ,O;TYHZAX+DO[RTNOMT<4B(
MB74<(N(89@K%OECCG4 DL?O[_P#'KJ* \C'T_3-1M-<O[R:]LI;:Z;<(H[)D
ME7 "J#(9"&  _NCDYXZ5I6RW"Q$74L4LFYB&BC*#;D[1@LW(& 3GD\X'2IJ*
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M;%3@\'! ZU7_ .$>U3_H<]<_[\V7_P CT>._^2>>)?\ L%77_HIJZ"@#G_\
MA'M4_P"ASUS_ +\V7_R/1_PCVJ?]#GKG_?FR_P#D>N@HH Y__A'M4_Z'/7/^
M_-E_\CT?\(]JG_0YZY_WYLO_ )'KH** .?\ ^$>U3_H<]<_[\V7_ ,CT?\(]
MJG_0YZY_WYLO_D>N@HH Y_\ X1[5/^ASUS_OS9?_ "/1_P (]JG_ $.>N?\
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MN@H Y_\ X1[5/^ASUS_OS9?_ "/1_P (]JG_ $.>N?\ ?FR_^1ZZ"B@#G_\
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MC' 'U.I_PCVJ?]#GKG_?FR_^1Z/#W_(<\6?]A6/_ -(K6N@H Y__ (1[5/\
MH<]<_P"_-E_\CT?\(]JG_0YZY_WYLO\ Y'KH** .?_X1[5/^ASUS_OS9?_(]
M'_"/:I_T.>N?]^;+_P"1ZZ"B@#G_ /A'M4_Z'/7/^_-E_P#(]6/"=]<:GX-T
M._O)/,NKK3[>:9]H&YVC4L<#@9)/2MBN?\"?\D\\-?\ 8*M?_12T =!1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %8^C?\ 'YJ'_70?S:MBL?1O
M^/S4/^N@_FU &Q1110 4444 %%%% !6/JO\ R$]._P"N@_\ 0A6Q6/JO_(3T
M[_KH/_0A0!L4444 <_X[_P"2>>)?^P5=?^BFKH*Y_P =_P#)//$O_8*NO_13
M5T% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110!S_ ([_ .2>>)?^P5=?^BFKH*Y_QW_R3SQ+_P!@JZ_]%-70
M4 %%%% !1110 5S_ (R_Y =M_P!A73?_ $MAKH*Y_P 9?\@.V_["NF_^EL-
M'04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!S_ (-_Y =S
M_P!A74O_ $MFKH*Y_P &_P#(#N?^PKJ7_I;-704 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '/^'O\ D.>+
M/^PK'_Z16M=!7/\ A[_D.>+/^PK'_P"D5K704 %%%% !1110 5S_ ($_Y)YX
M:_[!5K_Z*6N@KG_ G_)//#7_ &"K7_T4M '04444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !6/HW_ !^:A_UT'\VK8K'T;_C\U#_KH/YM0!L4444
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M7)D%O$)KJ&\2&W,JY.YHQ/N'H0H(.>=P -- S,E^&,<,9DE^('C:-%ZL^LX
M_'93O^%6?]3[XY_\''_V%6[&SU>"\UR2_MKZ>TEB?RA-(3O+=%5!/(OMD)'C
MT.21V%LDD5I#'*^^1457;U(')I=+AU.$_P"%6?\ 4^^.?_!Q_P#84?\ "K/^
MI]\<_P#@X_\ L*] HH \_P#^%6?]3[XY_P#!Q_\ 84?\*L_ZGWQS_P"#C_["
MO0** //_ /A5G_4^^.?_  <?_84?\*L_ZGWQS_X./_L*] HH \__ .%6?]3[
MXY_\''_V%'_"K/\ J??'/_@X_P#L*] HH \__P"%6?\ 4^^.?_!Q_P#84?\
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M_P!?U_PH^PZK_P _Z_K_ (5L44 8_P!AU7_G_7]?\*/L.J_\_P"OZ_X5L44
M8_V'5?\ G_7]?\*/L.J_\_Z_K_A6Q10!C_8=5_Y_U_7_  H^PZK_ ,_Z_K_A
M6Q10!C_8=5_Y_P!?U_PH^PZK_P _Z_K_ (5L44 8_P!AU7_G_7]?\*/L.J_\
M_P"OZ_X5L44 8_V'5?\ G_7]?\*/L.J_\_Z_K_A6Q10!C_8=5_Y_U_7_  H^
MPZK_ ,_Z_K_A6Q10!C_8=5_Y_P!?U_PH^PZK_P _Z_K_ (5L44 8_P!AU7_G
M_7]?\*/L.J_\_P"OZ_X5L44 8_V'5?\ G_7]?\*/L.J_\_Z_K_A6Q10!C_8=
M5_Y_U_7_  H^PZK_ ,_Z_K_A6Q10!C_8=5_Y_P!?U_PH^PZK_P _Z_K_ (5L
M44 8_P!AU7_G_7]?\*/L.J_\_P"OZ_X5L44 8_V'5?\ G_7]?\*/L.J_\_Z_
MK_A6Q10!C_8=5_Y_U_7_  H^PZK_ ,_Z_K_A6Q10!C_8=5_Y_P!?U_PH^PZK
M_P _Z_K_ (5L44 8_P!AU7_G_7]?\*/L.J_\_P"OZ_X5L44 8_V'5?\ G_7]
M?\*/L.J_\_Z_K_A6Q10!C_8=5_Y_U_7_  H^PZK_ ,_Z_K_A6Q10!C_8=5_Y
M_P!?U_PH^PZK_P _Z_K_ (5L44 8_P!AU7_G_7]?\*/L.J_\_P"OZ_X5L44
M8_V'5?\ G_7]?\*/L.J_\_Z_K_A6Q10!C_8=5_Y_U_7_  H^PZK_ ,_Z_K_A
M6Q10!C_8=5_Y_P!?U_PH^PZK_P _Z_K_ (5L44 8_P!AU7_G_7]?\*/L.J_\
M_P"OZ_X5L44 8_V'5?\ G_7]?\*/L.J_\_Z_K_A6Q10!C_8=5_Y_U_7_  H^
MPZK_ ,_Z_K_A6Q10!C_8=5_Y_P!?U_PH^PZK_P _Z_K_ (5L44 8_P!AU7_G
M_7]?\*/L.J_\_P"OZ_X5L44 8_V'5?\ G_7]?\*/L.J_\_Z_K_A6Q10!C_8=
M5_Y_U_7_  H^PZK_ ,_Z_K_A6Q10!C_8=5_Y_P!?U_PH^PZK_P _Z_K_ (5L
M44 8_P!AU7_G_7]?\*/L.J_\_P"OZ_X5L44 8_V'5?\ G_7]?\*/L.J_\_Z_
MK_A6Q10!C_8=5_Y_U_7_  H^PZK_ ,_Z_K_A6Q10!C_8=5_Y_P!?U_PH^PZK
M_P _Z_K_ (5L44 8_P!AU7_G_7]?\*/L.J_\_P"OZ_X5L44 8_V'5?\ G_7]
M?\*/L.J_\_Z_K_A6Q10!C_8=5_Y_U_7_  H^PZK_ ,_Z_K_A6Q10!C_8=5_Y
M_P!?U_PH^PZK_P _Z_K_ (5L44 8_P!AU7_G_7]?\*/L.J_\_P"OZ_X5L44
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..BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>proxy_002.jpg
<TEXT>
begin 644 proxy_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2X Z0# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[6]CU>[\UC"1\HCPG9N<'BJVD_#;5M*T[Q)%!K"0W=VAMM*N(R<VML&9E0\
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M3IGO5>'P;K\*:;IZS:<-/T_5FOTG\QS+(K,[;2FW"D;S_$0<=J2;M]WZ7_5
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M\BAF=$*;0%(+#+;SG'3FI]6\!6U[?:(4,ES9V=\;JXBU&]GN2P$;*NWS"_\
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M4#KW/Z\5Q6B_\(_IVL:=>W'C#0)8X+0&=!?1_/=_.#(.>F)''Y<4[4/&-O\
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M110 4444 %%%8/B'5M>TR2W&C>&9-95PQD9+V*#RB,8'S]<\]/2@#>HKA_\
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M /!S;?XUT-EJ.KS^'9+ZZT)[74E21DTXW4;EV&=J^8/E&[ Y[9YH UZ*X?\
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M;_&NAT/4=7U#399]5T)]*NE<JELUU',74 $-N3@9)(P?2@#7HKA_^$J\<?\
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M=$,97R0;Z.Y\W.<_<^[C Z]<^U &]17!'Q9X_#$#X9,1G@_V[;_X4#Q9X_+
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MF;J#D;?>@#UNBO 8_P!FZYFC66\\7M]I< R[;,N-W?#&0$_4@?2G_P##-/\
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M1_PS3_U-\G_@!_\ ;: />Z*\$_X9I_ZF^3_P _\ MM'_  S3_P!3?)_X ?\
MVV@#WNBO!/\ AFG_ *F^3_P _P#MM'_#-/\ U-\G_@!_]MH ][HKP3_AFG_J
M;Y/_   _^VT?\,T_]3?)_P" '_VV@#WNBO!/^&:?^IOD_P# #_[;1_PS3_U-
M\G_@!_\ ;: />Z*\$_X9I_ZF^3_P _\ MM'_  S3_P!3?)_X ?\ VV@#WNBO
M!/\ AFG_ *F^3_P _P#MM'_#-/\ U-\G_@!_]MH ][HKP3_AFG_J;Y/_   _
M^VT?\,T_]3?)_P" '_VV@#WNBO!/^&:?^IOD_P# #_[;1_PS3_U-\G_@!_\
M;: />Z*\$_X9I_ZF^3_P _\ MM'_  S3_P!3?)_X ?\ VV@#WNBO!/\ AFG_
M *F^3_P _P#MM'_#-/\ U-\G_@!_]MH ][HKP3_AFG_J;Y/_   _^VT?\,T_
M]3?)_P" '_VV@#WNBO!/^&:?^IOD_P# #_[;1_PS3_U-\G_@!_\ ;: />Z*\
M$_X9I_ZF^3_P _\ MM'_  S3_P!3?)_X ?\ VV@#WNBO!/\ AFG_ *F^3_P
M_P#MM'_#-/\ U-\G_@!_]MH ][HKP3_AFG_J;Y/_   _^VT?\,T_]3?)_P"
M'_VV@#WNBO!/^&:?^IOD_P# #_[;1_PS3_U-\G_@!_\ ;: />Z*\$_X9I_ZF
M^3_P _\ MM'_  S3_P!3?)_X ?\ VV@#WNBO!/\ AFG_ *F^3_P _P#MM'_#
M-/\ U-\G_@!_]MH ][HKP3_AFG_J;Y/_   _^VT?\,T_]3?)_P" '_VV@#WN
MBO!/^&:?^IOD_P# #_[;1_PS3_U-\G_@!_\ ;: />Z*\$_X9I_ZF^3_P _\
MMM'_  S3_P!3?)_X ?\ VV@#WNBO!/\ AFG_ *F^3_P _P#MM'_#-/\ U-\G
M_@!_]MH ][HKP3_AFG_J;Y/_   _^VT?\,T_]3?)_P" '_VV@#WNBO!/^&:?
M^IOD_P# #_[;1_PS3_U-\G_@!_\ ;: />Z*\$_X9I_ZF^3_P _\ MM'_  S3
M_P!3?)_X ?\ VV@#WNBO!/\ AFG_ *F^3_P _P#MM'_#-/\ U-\G_@!_]MH
M][HKP3_AFG_J;Y/_   _^VT?\,T_]3?)_P" '_VV@#WNBO!/^&:?^IOD_P#
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M!_\ ;: />Z*\$_X9I_ZF^3_P _\ MM'_  S3_P!3?)_X ?\ VV@#WNBO!/\
MAFG_ *F^3_P _P#MM'_#-/\ U-\G_@!_]MH ][HKP3_AFG_J;Y/_   _^VT?
M\,T_]3?)_P" '_VV@#WNBO!/^&:?^IOD_P# #_[;1_PS3_U-\G_@!_\ ;: /
M>Z*\$_X9I_ZF^3_P _\ MM'_  S3_P!3?)_X ?\ VV@#WNBO!/\ AFG_ *F^
M3_P _P#MM'_#-/\ U-\G_@!_]MH ][HKP3_AFG_J;Y/_   _^VT?\,T_]3?)
M_P" '_VV@#WNBOG^X_9[UK2(_MWA_P 6LVI0G=$#"UOGZ.KL0?PQ[BNP^"WC
MK5?&&D:E9ZX1)J&F2HK3; A=7W8# <;@489&.W?)(!ZA1110 4444 %%%% !
M7B/Q:_Y+!\//^OR'_P!*$KVZO$?BU_R6#X>?]?D/_I0E 'MU%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #)7\N)WQG:I./7%>
M7_\ "YX_^$$;Q%_83_:A=_9A8?:>2-F_?OV=-F3TKU"9#)!(@QEE(&?I7CP^
M$&L#3C!]OLLG2&M?+WOL^U$E1)]WIL.,XS[4M>;RT_/7\-!]%_7]=_D=I-X^
M@MKG4H)K%]UI]E2$))EKB2<?*@! VX/?/O3]8\5:OX>\.ZEJFIZ!$ILXUD00
M7X>.7+;=NXH&4C.3\A'H36==> KR[O=4N6NK>-Y6L9K1@6;;+;C^,8'RD\<'
MH:M^(]$\3>*?"FJZ5=KI%H]S$B0QQS22@,&!+-(47@@?="?C0]M-_P#@D0O=
M<W];$\'C"XMM5:PUW3[>R/V![]9K6[:X01H0&W;HT*GGC@@\\T6WB^\\K3KW
M4-'6TTO4I$CMYQ=!Y$+CY/-3: N>!\K-R1FJ%K\/4T[5M1BL([*'0=7LC!>V
MB+L:.7;MWQ +C!'49'/-3+X9UR^M-)TC57T\Z;ILL,IGA=VENO*^X"A4"/D
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M?I_P;BN[_P!>?_ L;E%%%!04444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 5XC\!O^1E\??]?D7_ *'/7MU>(_ ;_D9?'W_7Y%_Z'/0!
M[=1110 4444 %%%% !7B/Q:_Y+!\//\ K\A_]*$KVZO$?BU_R6#X>?\ 7Y#_
M .E"4 >W4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %>(_ ;_D9?'W_ %^1?^ASU[=7B/P&_P"1
ME\??]?D7_H<] 'MU%%% !1110 4444 %>(_%K_DL'P\_Z_(?_2A*]NKQ'XM?
M\E@^'G_7Y#_Z4)0![=1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M&EP,#<>^!QS4.G:1IFD1O'IFG6EDDC;G6V@6,,?4A0,FFM'\O\_Z^0K.V_\
M5E_7S+M%%%!04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7B/P&_P"1E\??]?D7
M_H<]>W5XC\!O^1E\??\ 7Y%_Z'/0![=1110 4444 %%%% !7B/Q:_P"2P?#S
M_K\A_P#2A*]NKQ'XM?\ )8/AY_U^0_\ I0E 'MU%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %>(_ ;_D9?'W_7Y%_Z'/7MU>(_ ;_D9?'W
M_7Y%_P"AST >W4444 %%%% !1110 5XC\6O^2P?#S_K\A_\ 2A*]NKQ'XM?\
ME@^'G_7Y#_Z4)0![=1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !7B/P&_Y&7Q]_P!?D7_H<]>W5XC\!O\ D9?'W_7Y%_Z'/0![=1110 44
M44 %%%% !7B/Q:_Y+!\//^OR'_TH2O;J\1^+7_)8/AY_U^0_^E"4 >W4444
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M.(NQ7(3'!/S-G@5U6N:9_;.@W^F>=Y/VNW>#S-N[9N!&<9&>OK5O9V_K:_\
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MVO%&J3Z)X5U35+9(WGM+9YHUD!*DJ,C(!!Q^-9UYX2EGU"ZOH-02*:;4(+Y
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MR(R1QE5D.\DL7<C* @<9]353X=W;6:6MQKJ210:9)IEMML]I1&*%68[SN8;
M#C /MWT?^$-EEMKM)]21IKK4[;47=+<JH:(194*7/!\KKGC=WQS?N\S[?\'_
M ")?/;^M]27_ (3G3A-\UI?):N\L<%XT:B*=XPQ94^;=GY6P6 !QP33+3Q?+
M?2QM;Z+J+"6T%U%:E(%EE0LH#AC-M PWW6P>/P-?_A!9F2*SDU<-I=K+--:6
MXML/&\BN/G?=AU7>V %4^I-2WWA"\EMH$L=86UFCTY+ R-;%]RAE+'AU(W!2
M."",Y!S6>ME_7]:_AYE.]_+_ (/^7X^1)%XWAFM(9$T753<SSR0PV8$)DE\O
M[[*PDV;1TR6Z]*1_&MH[)<0_+80V,E_>O(A\R-%)4(%'1MROG_<([Y%74? \
MVL6E@NH3:+/<:>66V1M(+6HC8 %6A:4Y/RC!##'YYDM/"4VDWD2V!B2*?3WL
MIYK>WBB$+!F='6+&S&7<8P>HSGDT]?Z]/Z^8=K_UJ6)O%DK^&[O6(-,N;=;,
M+-)'=JI\R'JS(\;LI.W)X)P1@@5T4DX^Q-<1$,/++J>QXR*XI?!-UI^AZU:V
MKVCW&KJEO(ME:BT@B4Y5Y?+WM\^UB20>< 8KM/LRK8_94.U!'Y:D\X&,43OR
MRY=^GW/];!'=<W]:K_@G%:;\0S=>'+>YO;&XLKV73TO%=H%:*8917,:B3=@,
MXX8J<$'FM.;QU:0ZB]F-+U20K=M9+*D:;))PNX(,OGD=R H[D54E\ >9IFF6
M?]IX^PZ4=.W^1]_+1'?C=Q_JNG/WNO'.C_PBG^E13?;?]7JS:GCRNN8RFSK[
MYS^E5*W.[;?\'_(E<W]?UW-/1=7@US2X[^WCEC5F=&CF #HZ,593@D9# C@D
M>]<_'XVDBU;5K*ZTJZ+6]\EG91P>67N6,0D(&9, XRV3M 7&><@;F@:/_8>F
MO9^?Y^ZYGGW[-O\ K)6DQC)Z;L9[XK&O/!MQ+K5SJEIJD<$[7:7EOOM3((Y!
M%Y3!OG&]&7M\I!YS2Z^7_#?\$O[+[_\ #_\  -W1]8M]:LFN8(YHBDC0RPS*
M%>*13AE8 D9'L2#V-:%9>@Z0VCV4L<UT;JYN)WN)YMFP,[==JY.T#  &3TZF
MM2@2OU"BBB@84444 %>(_ ;_ )&7Q]_U^1?^ASU[=7B/P&_Y&7Q]_P!?D7_H
M<] 'MU%%% !1110 4444 %>(_%K_ )+!\//^OR'_ -*$KVZO$?BU_P E@^'G
M_7Y#_P"E"4 >W4444 %%%% !1110!%<7,%G;O<7,T<$*#+R2N%51[D\"J,?B
M30I7M4CUK3G>[S]F5;I"9L'!V<_-SZ5!XMT^?5?"]]8VT0EFF0*J$@;OF&>3
MQTKDO$'A35KOQ#JC1+J$MGJ(@"_9)+2-(_+ &)&E1I%P1N!CSUZ \TD_>L)N
MRT.VBU_1I[YK&'5["2\0,6MTN4,@"G#94'/!!!],5#_PE7AW[/\ :/[>TOR?
M,$7F?;(]N\C(7.<9P0<5Y_H6G:AJBSVUOI.R.WU^[NFU%I(P& =U*@ []QSM
MY &._:K!\)ZW:Z;X:=(+T/::1]AN8+%K0R([!=V?/#(5.""5.?K1=\J?I^*O
M_P #\=AOXFOZ_KJ>A3ZSI=K>V]G<:E9PW5SS!!).JO+_ +JDY;\*$UG2Y+Z:
MQ34K-KN!=\T"SJ9(U]67.0/K7 3>%=7LFTZ/3[&[,JVUM%+))=6]Q;/Y9R!.
MLBJV5_A:)<GVIFG^$-:@O4@G3476VN+JX2436BVS>8'QC$?G,3N *L0.^XX%
M$G:]NE_PO;^ON$FW^!V%[XU\.66EWFH?VQ8W$5I&LDJV]S&[ -]W^+OD8SUS
M6K+J5C!IW]H37MO%9;!)]HDE58]IZ'<3C'O7G,O@[5U\/Z7:V^GJLL'AR6SE
M19$'[\M$P3K@Y*OST]^:ZWQ$NJW.A6<FGZ8);E9HI)()5B>6$#DE S",N#C^
M+'7!Z54E:]N_^:_X),6V]5T+TGB?0(K2*[DUS3$MIE+1S-=QA' (!(;." 2/
MS%-U?Q-H^B:<;V\O[=4,+30H)D#SA5W8C!(W''I7%>&_"FLP>([:]U2P/EI-
M?R-)+)"Q_>^5L.$P,D!@<#C!]B:8\*:]9>&Y[3^Q3?37F@IIPC$\0^S2+YA^
M8LP&T[UY7/*CZU.MC2.K5]CT#5/$VF:-I]G>W\ZP0WDL446]E4[GZ9R0.!R?
M8&KD6KZ9/J$FGPZC:27L0S);).ID0>I4'(K&UW3[Z7PYIL=M:-<7%I<6LSP(
MZ*S!&4L 6(7. >I%8>F>']6CN]'LI=+\A=,U":[DU$RQD7"N'X4*=^YMXW;@
M!\O4\57VFNE_P,TY<J;[+[SN9=0LH//\Z[MX_LZ"2;?(!Y2'.&;)X'!Y/H:@
M?7-)COC8OJEDMX(_--N;A!)LQG=MSG'O7->+?#VJ:GX@TR73XT-E<[;?526
M(A1Q(IY//(9<#/#FJ+^'M7-VVG#3B5.MC4QJQECVB/?OV8W;]^/D^[C'?M4J
M[_K^O7SU*D[?U_7:WS1TECXS\/7VDVNIC5K*"VNG,<)GN(TW.#C:/FP3[=:W
MNM>3_P#"*>($CM6>SU%52RET^2&TDLB3F1FWDS!AY; CIAQCE37H.A2B"W71
MS'.)=/MX4>25U<-E>S#&2,<Y5?7'-$7=?U_7_#^0KM.Q976M*;5#I:ZG9'4
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M!#D!<#KVK2\,^'+_ $J[\,-)9K#'9Z&]K=;77Y9BT1"\'G[KG(R/?FE'7?\
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M5[+JK[;;[-/$0P'5LLX!'TR3T -.U;QGHVC:A<6%S/FZ@MA=/$C)NV%MO +
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M'Y?QJ>QU&RU2U6ZT^\M[NW8D++;RK(A(ZX()%>9:?X+U7^ST@OK#4YC9Z?\
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M273&8HH#2L<!E^;E/?K[5C>*/#>NW/B74-:T>W0W<-M:_87>10'D5I5D4\Y
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MHJKWZ 8'09QFMFF]QIW6H4444AA1110 5XC\!O\ D9?'W_7Y%_Z'/7MU>(_
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M5X]+XD\0ZGX=O9[Q;K['?V-ZKQSFT2./;&Y7R@K^<2,88.#USA<8K4EUS7-
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M4 %%%% !7B/Q:_Y+!\//^OR'_P!*$KVZO$?BU_R6#X>?]?D/_I0E 'MU%%%
M!1110 4444 %4=1T;2M8$8U/3+.]$1W1BY@638?4;@<&IKZ*ZGLI8K.Z6UN&
M&$F:+S-GOM)&3C_)Z5P-QKVK69GMVUV1M)34$MI-;EBA5X5\MC)D[!%PX5-Q
M7 +$'D4KZV!G<7>BZ5J#6[7NF6=RUL<P&:!7,1_V<CY?PJ7^SK'>S_8[?<\H
MG8^4N6D  #GC[P  SUX%9'A#67UK29Y7G^T_9[N6V6XV;?.56^5\  9(QR
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M^59BH.<[1C/7@<>])/2ZZ?\ !!M<W*6+O1-)U".:.]TNRN4G=7E6:W1Q(RC
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M<(L<TL=O#(TB*20C"5'4KR>"#C)Q3M!T*S\.Z8+&RWE-YD9W"@NQZG"@*.W
M  QP*R!XS1;D6DEGBY2ZEAF02YV1)'YGF_=YRI3CU;&>*K>%OB%9^)=3CLE%
MBKSVYN8%MK]+AU0$ K*J@>6_S XRPZ\\4+>R)NK)_P!?U_P#I4T72H[Z>^33
M+);R<;9KA8%$D@]&;&2/K5J"WAMK>.W@ACB@C4(D<:A551P  . *COI'AT^Y
MEC.'2)F4XZ$ US+ZY?IX;\+7AGS/>RVZW!VK^\#1EF'3 R1VQ4N22U\OQO\
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MIM&S<JL1@MTYQ3G[K:?2_P"O^3]1HZZ"WAM;>.WMXHX8(E"1QQJ%5%'   X
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MD+6I0$+Y8"A<X)!+*2P^\35FX\9:!;>27U ,LT2S"2*)Y$2-ONN[*"$4]BQ
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MUW=%)*SO_6UA-7W/.[KP1K$L7VE4TXZE-/-.T\5W/:O:M(1CRY$&9%  RK*
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %>(_ ;_D9?'W_ %^1?^ASU[=7B/P&_P"1E\??]?D7_H<] 'MU%%%
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M *'/7MU>(_ ;_D9?'W_7Y%_Z'/0![=1110 4444 %%%% !7B/Q:_Y+!\//\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "O$?@-_R,OC[_K\B_\ 0YZ]NKQ'X#?\C+X^_P"OR+_T.>@#VZBB
MB@ HHHH **** "O$?BU_R6#X>?\ 7Y#_ .E"5[=7B/Q:_P"2P?#S_K\A_P#2
MA* /;J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ KQ'X#?\C+X^_Z_(O\ T.>O;J\1^ W_ ",OC[_K\B_]#GH
M]NHHHH **** "BBB@ KQ'XM?\E@^'G_7Y#_Z4)7MU>(_%K_DL'P\_P"OR'_T
MH2@#VZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O$?@-_
MR,OC[_K\B_\ 0YZ]NKQ'X#?\C+X^_P"OR+_T.>@#VZBBB@ HHHH **** "O$
M?BU_R6#X>?\ 7Y#_ .E"5[=7B/Q:_P"2P?#S_K\A_P#2A* /;J*** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MA4L526V4%EVD@31CD'H?:E';[OR_X K:_?\ F>[T444QA1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %>(_ ;_D9?'W_ %^1?^ASU[=7B/P&_P"1
ME\??]?D7_H<] 'MU%%% !1110 4444,#S*?PQJ2/,;K0Q=WWSD:R=:DC R20
MVWJF./E4$#&!7,?$U)8OBE\-(YYO/F6>W#R@8WL)X\M^)YKI+ZUU:]CN;74X
M?%<U_*)$,=NL+6+Y)V@ _*4QC[_.,YYKF?B7'+%\3_AE'.L:3)-;JZQ#"!A-
M'D+[9Z4H_#]WY?U<3^/[_P _ZL>[4444QA1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %>(_ ;_D9?'W_7Y%_P"ASU[=7B/P&_Y&7Q]_U^1?^AST
M >W4444 %%%% !1110!Q.IZKXJOK#4K5?"*^3B6$2#5"CN!D!E 0-SU&#GWK
MS[XD>9_PLOX8><A27S;;>K9RI\Z/(.>?SKH)9O%#71BN-.\6O!.\HO\ R&M]
MKC=\@@)D!C7'!(P<>_-8?Q054^*OPV1(FB1;B +&W5!Y\?!Y/(^M*/PW]/R_
MX(G\7W_F>YT444QA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>
M(_ ;_D9?'W_7Y%_Z'/7MU>(_ ;_D9?'W_7Y%_P"AST >W4444 %%%% !1110
M 5XC\6O^2P?#S_K\A_\ 2A*]>AU[2+B:[A@U.TEFLP3<QQS*S18Z[@#D5X_\
M594G^+7PYEB8-&]U RL.A!G0@T >X4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 5XC\!O^1E\??]?D7_H<]>W5XC\!O^1E\??]?D7_ *'/
M0![=1110 4444 %%%% '+S^"+*;P_'IJS/#<0JZV]]$@66/<3D?[0P<$'@]Z
M\@\93RS?$7X=1RE2;;4_LJE1C*Q7@C4GGKA1FO4[JY\<[+S9=>'(%$CQ0ADD
MWGKLY\S:&/'!_*O.?B+;&U^)OPUC>-8YC=0O,% &96N$+GCC)8D_C2C:S^7]
M?<)VOY_U^I[U1113&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M[_UO?\VR>56M_6UOR.>\9^%V\6:+'917[6%Q#<1W,%R(A)L=#D$J2 :QM5\
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M** "BBB@ HHHH *\1^ W_(R^/O\ K\B_]#GKVZO$?@-_R,OC[_K\B_\ 0YZ
M/;J*** "BBB@ HHHH *\0^+CJGQ=^'SNP55NXB6)P //2O;Z\\^*_P .)O'V
MF64EA=1VVIV#,T+2Y".K8RI(Y!RH(//?UR #T.BO [7QE\:M#A_LZZ\+#4I(
M3M^TR6CR%AV^:-@K?7KZU-_PLCXP_P#0AQ?^ $__ ,<H ]VHKPG_ (61\8?^
MA#B_\ )__CE'_"R/C#_T(<7_ ( 3_P#QR@#W:BO"?^%D?&'_ *$.+_P G_\
MCE'_  LCXP_]"'%_X 3_ /QR@#W:BO"?^%D?&'_H0XO_   G_P#CE'_"R/C#
M_P!"'%_X 3__ !R@#W:BO"?^%D?&'_H0XO\ P G_ /CE'_"R/C#_ -"'%_X
M3_\ QR@#W:BO"?\ A9'QA_Z$.+_P G_^.4?\+(^,/_0AQ?\ @!/_ /'* /=J
M*\)_X61\8?\ H0XO_ "?_P".4?\ "R/C#_T(<7_@!/\ _'* /=J*\)_X61\8
M?^A#B_\  "?_ ..4?\+(^,/_ $(<7_@!/_\ '* /=J*\)_X61\8?^A#B_P#
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MQ?\ @!/_ /'* /=J*\)_X61\8?\ H0XO_ "?_P".4?\ "R/C#_T(<7_@!/\
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M&'_H0XO_   G_P#CE'_"R/C#_P!"'%_X 3__ !R@#W:BO"?^%D?&'_H0XO\
MP G_ /CE'_"R/C#_ -"'%_X 3_\ QR@#W:BO"?\ A9'QA_Z$.+_P G_^.4?\
M+(^,/_0AQ?\ @!/_ /'* /=J*\)_X61\8?\ H0XO_ "?_P".4?\ "R/C#_T(
M<7_@!/\ _'* /=J*\)_X61\8?^A#B_\  "?_ ..4?\+(^,/_ $(<7_@!/_\
M'* /=J*\)_X61\8?^A#B_P# "?\ ^.4?\+(^,/\ T(<7_@!/_P#'* /=J*\)
M_P"%D?&'_H0XO_ "?_XY1_PLCXP_]"'%_P" $_\ \<H ]VHKPG_A9'QA_P"A
M#B_\ )__ (Y1_P +(^,/_0AQ?^ $_P#\<H ]VHKPG_A9'QA_Z$.+_P  )_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
'%%%% '__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
